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ABSTRACT
The reversal o f 3-phenethylbiguanide (phenformin) in tox ica tion  in 
mice by disodium succinate confirm ed the hypothesis tha t substrates 
which transfer reducing equivalents d irec tly  to ubiquinone in the 
m itochondria l respiratory chain, e ffe c tive ly  bypass the locus o f 
resp ira tory inh ib ition by biguanide anti-d iabetic  agents in the 
m itochondria l oxidation o f substrates requiring NAD’*’ as co -fac to r.
Although phenform in bound to live r m itochondria and sub- 
m itochondria l partic les, the drug had no d irec t inh ib ito ry  action upon 
NADH-ubiquinone oxidoreductase or succinate-ubiquinone oxido- 
reductase in sub-m itochondrial partic les. In coupled m itochondria, 
phenform in caused a concentration-dependent inh ib ition o f 2-oxo- 
g lu ta ra te  oxidation and succinate oxidation. In the absence o f ex tra - 
m itochondria l Ca^^, the oxidation o f 2-oxoglutarate was less susceptible 
to inh ib ition  by phenform in: inh ib ition  o f succinate oxidation was 
unaffected.
Selective use o f various m itochondria l Ca^^ transport inh ib itors 
indicated tha t s ign ifican t Ca^^ re -d is tribu tion  may occur during the 
isolation o f m itochondria. Exposure o f guinea-pig, ra t or hamster live r 
m itochondria to phenform in during the isolation procedure resulted in 
decreased m itochondrial Ca^^. Novel isolation conditions were developed 
to determ ine m itochondria l Ca^^ content considered to re fle c t tha t in 
v ivo . The adm in istra tion o f phenform in to rats, guinea pigs or hamsters 
resulted in decreased m itochondria l Ca^^ which corre lated inversely 
w ith  raised blood lacta te  concentrations; 2-oxoglutarate oxidation, but 
not succinate oxidation, was inhib ited in these m itochondria l 
preparations.
A mechanism o f action o f phenformin-associated lactic-acidosis 
a ttribu tab le  to impaired ATP production arising from  inactiva tion  o f 
Ca^^-sensitive, NAD^-dependent m itochondrial dehydrogenases (e.g. 2- 
oxoglutarate dehydrogenase) due to a lte ra tion  o f m itochondria l calcium  
content is proposed.
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CHAPTER ONE
TOXICOLOGY OF ALKYL-BIGUANIDES
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1.1 HISTORY, PHARMACODYNAMICS AND THERAPY
The history o f the therapeutic use o f biguanides has recently been 
reviewed (Table 1.1) by Schafer (1983). The application o f guanidines in 
therapy orig inated from  the observation tha t there was a relationship 
between the concentrations o f blood sugar and o f in jected guanidine 
hydrochloride (Watanabe, 1918). Whereas guanidine (Figure 1.1) its e lf 
appeared too tox ic  fo r use in chemotherapy, diguanides (Synthalin) were 
more readily to le ra ted  (Frank e t W., 1926; Frank e t al., 1928) and used in 
the oral trea tm ent o f diabetes m ellitus fo r some years. Although S lotta 
and Tschesche (1929) reported the synthesis o f a number o f a lky l- 
biguanides tha t had hypoglycaemic a c tiv ity  and an apparently lower 
to x ic ity  than guanidines, these findings were not fu lly  explored u n til the 
1950's when Ungar et al,, (1957) reported the hypoglycaemic e ffe c t o f
3-phenethylbiguanide (phenform in). A number o f biguanides have since 
been evaluated as po tentia l hypoglycaemic agents; only phenform in, 
buform in and m etfo rm in  (Figure 1.1) became o f c lin ica l in terest.
The pharmacodynamic e ffec ts  o f hypoglycaemic biguanides are 
summarised in Table 1.2; the mechanism o f hypoglycaemic action is not 
com plete ly understood but i t  has been suggested tha t a ll hypoglycaemic 
biguanides exert the same fundamental e ffec ts  modulated p rim a rily  by 
th e ir d iffe re n t pharm acokinetic properties (Cook et ^ . ,  1973; Schafer, 
1983). O f the therapeutic biguandies, m etfo rm in  is considered to have 
the highest e lim ination rate : phenform in, the slowest (Schafer, 1983). 
M etform in is excreted unmetabolised in laboratory animals and man 
(Hermann, 1979); buform in is metabolised in most laboratory animals by 
hydroxylation to give l-(3-hydroxybutyl)-b iguanide (Beckmann, 1967) but 
appears to be excreted unchanged in man (Beckmann, 1968). In contrast, 
phenform in appears to be metabolised by most species: l - [  2-(4-
hydroxy)-phenyl-ethyl ] -biguanide (4-hydroxyphenform in) is the only
- 2 -
TABLE 1.1 History o f <>ral diabètes treatrnenl by guantdines and
biguanides
Year Observation! Event
1918 Discovery of blood sugar lowering effect of guanidines.
1926 Experimental use of diguanidines as hyp>ogIycacmic
agents.
1928 First clinical observations with synthalin-A ; clinical
applications of galegine.
1928 Hepatotoxic action of diguanidines recognized.
1932 All diguanidine containing drugs prohibited and with­
drawn.
1953 Biguanides as new hypK)glycaemic agents introduced.
1955 Inhibition of cellular respiration by biguanides and
guanidines discovered; first explanation of toxicity on 
molecular basis.
1957 Clinical application of biguanides.
1959 First reports on non ketotic metabolic acidosis in
biguanide treated diabetics.
until Unlimited use of biguanides ; although molecular mecha-
1975 nism of action not resolved.
1976 UGDP-study. Limitations on the use of biguanides 
suggested.
1976 Large number of fatal cases of lactic acidosis due to
biguanide treatment reported.
1976 Unifying concept of mode of action published, including 
toxicity. Explains biguanide effects as primary actions on 
biomembranes.
1977 Withdrawal of phenformin in USA, Canada.
1977-78 Withdrawal of phenformin in Scandinavia.
1978 Phenformin and buformin abandoned in Germany.
1979 Limited use of metformin approved in most European
countries. Directions on careful checking for adverse 
effects.
1980 Ending of the Canadian metformin monitored program.
1980 Methodological criticism of the UGDP-study.
From Schafer (1983)
(UGDP, U nivers ity  Group Diabetes Program)
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NH
1
HN2” ” C NH2 Guanidine
NH NH Guanylguanidine
ll II (biguanide)
H2N— C — NH—  C—NH2
NH NH Diguanidines:
II II (n = 10, Synthalin A;
H2N—C NH (CH2)—NH— C— NH2 n = 12, Synthalin B)
NH NH A lkyl biguanides:
^^/^^s:;^CH2CH2NH—C—NH—C—NH2 3-phenethylbiguanide
(phenformin)
CH3— (CH2 ) 3— NH— C— NH— C — NH2
NH NH N-butyl-biguanide
II II (buformin)
CH3 ll^ N-1,1-dim ethyl-biguanide
\ — C—  NH— C— NHp (metformin)
CH3
Figure 1.1. STRUCTURE OF GUANIDINE DERIVATIVES
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TABLE 1.2 PHARMACODYNAMICS 
GENERAL
1. Hypoglycaem ic biguanides, like  many hormones, exert m u lti-s ite  
e ffec ts  on metabolism; unlike hormones there appear to be no 
biguanide-specific receptors.
2. Biguanides exert th e ir hypoglycaemic e ffe c t by extrapancreatic 
actions; they do not cause an increase in insulin secretion (Boshell 
e t a l., 1968).
3. Mode o f action is m u ltifa c to ria l; extent to which individual 
b io log ica l e ffec ts  contribu te  to overall an ti-d iabetic  action is 
unclear.
4. Properties common to a ll hypoglycaemic biguanides:
(a) exist only as positively-charged species in physiological 
environments (Schafer, 1980).
(b) bind readily to b iological membranes (Schafer, 1980).
5. A ll hypoglycaemic biguanides exert the same fundamental e ffec ts  
modulated p rim arily  by d iffe re n t pharm acokinetic properties.
AN TI-D IABETIC  ACTION
1. Induction o f malabsorption (from  in testina l tra c t):
-  glucose and other sugars, amino acids, bile acids, fo lic  acid, 
w a ter (A rvanitakis et ^ . ,  1973; Caspary, 1977; Tomkin e t al., 1971; 
N icholls and Leese, 1984)
2. Inh ib ition o f increased hepatic and renal gluconeogenesis (Section
1.3.2).
3. Enhanced peripheral anaeorobic glycolysis (may be im portant only 
in to x ic ity ; Section 1.3).
4. Increased muscular uptake o f glucose, possibly mediated via 
increased insulin sensitiv ity  (B u ffe rfie ld  and Whichelow, 1968; 
Frayn, 1976; W ickmayer e t al., 1978; Holle et al., 1981).
5. A n ti- lip o ly t ic  e ffe c t and inh ib ition  o f free fa tty  acid oxidation 
(Muntoni et a l., 1970; Schonborn e t W., 1975; Schafer, 1983).
- 5 -
u
m etabolite  found in man (Beckmann, 1967; 1968); the O -g luc^on ide  o f 4- 
hydroxyphenform in is the m ajor m etabolite excreted in the urine o f the 
ra t and dog, and is also present in guinea-pig urine (A lka lay e t al., 1979).
4-Hydroxyphenform in has no reported hypoglycaemic a c tiv ity  in the 
guinea-pig (Guest, 1978) or the ra t (Guest et al. 1980). Genetic 
im pairm ent o f hydroxylative capacity results in a s ign ifican t decrease in 
the rate o f e lim ina tion o f phenform in in man (Shah et W., 1980; Idle and 
Islam, 1981) and may increase the risk o f phenform in-induced la c tic  
acidosis (Idle e t ^ . ,  1981; Oates e t al., 1981).
Biguanide therapy is p rim arily  o f use in the trea tm en t o f non­
insulin dependent (Type II, m aturity-onset) diabetes (see Bennett, 1983, 
fo r c lassifica tion o f diabetes); use o f biguanides may be indicated in the 
trea tm ent o f diabetogenic obesity w ith  hyperinsulinism, in sulphonylurea 
'secondary fa ilu re ', and in combination w ith  sulphonylureas in patients o f 
normal weight w ith  high insulin requirem ent or insulin resistance 
(Schafer, 1983). The use o f biguanides has been severely curta iled  since 
the mid-1970's when numerous reports appeared linking phenform in and 
buform in therapy w ith  la c tic  acidosis (Cohen and Woods, 1976). 
P re lim inary results from  the U n ivers ity  Group Diabetes Program (UGDP, 
1971) suggested an association o f phenform in w ith  increased m o rta lity , 
especially from  cardiovascular causes, and as a consequence the drug 
was w ithdrawn from  any fu rth e r investigation o f the chronic trea tm ent 
o f non-insulin dependent diabetes; publication o f the fin a l report o f the 
UGDP (1975) led to the subsequent w ithdraw al o f phenform in therapy in 
the United States (FDA, 1977). M etfo rm in  continues to  be o f c lin ica l 
benefit but is subject to m onitoring o f therapeutic e fficacy  and fo r 
adverse e ffec ts  (Lucis, 1983).
- 6 -
1.2 LAC TIC  ACIDOSIS
The pathogenesis and management o f la c tic  acidosis has recently
been reviewed (Cohen and Woods, 1983; Kreisberg, 1984). Production o f
lacta te  from  glucose oxidation in peripheral tissue, and the u tilisa tion  o f
lacta te  in hepatic and renal gluconeogensis is the basis o f the Cori cycle
A
(Cori, 1981). Lacta te  homeostasis is im portant in the maintainance o f 
acid-base balance: accumulated la c tic  acid is rapid ly and com plete ly
dissociated a t physiological pH; production o f H"  ^ is countered by 
bicarbonate buffering w ith  a resultant increase in the anion gap ( [N a^] - 
[C l + HCO^] ). Under normal conditions acid-base homeostasis is 
maintained by a combination o f renal H^-secretion/HC O ^ reabsorption 
and the u tilisa tion  o f lac ta te ; perturbation o f lacta te  homeostasis 
through increased lacta te  production, decreased lacta te  u tilisa tion , or a 
combination o f both, results in elevated blood lacta te  concentrations and 
a fa ll in systemic pH. Although there is no un ifo rm ly accepted lacta te  
concentration at which the diagnosis o f la c tic  acidosis is established, 
concentrations 5mM and a systemic pH 7.25 are ind ica tive  o f 
s ign ifican t la c tic  acidosis (Kreisberg, 1984). C lin ica l la c tic  acidosis may 
be classified in to two main categories (Cohen and Woods, 1976): type A 
la c tic  acidosis arises from  c ircu la to ry  insuffic iency o f any cause; in 
type B la c tic  acidosis the c ircu la tion  is c lin ica lly  normal, a t least a t the 
outset o f the condition. In 1976, more than ha lf o f a ll recorded cases o f 
type B la c tic  acidosis were re lated to the use o f phenform in (Cohen and 
Woods, 1976); the association between biguanide adm in istra tion and 
lac tic  acidosis has been reviewed by Kreisberg and Wood (1983).
The risk o f la c tic  acidosis from  biguanides is greatest w ith  
phenform in, in term ediate w ith  buform in and least w ith  m etfo rm in  (L u ft 
e t a l., 1978). The increased risk o f la c tic  acidosis w ith  phenform in and 
buform in may be due to subtle differences in pharmacodynamics: 
m etform in produces less marked abnorm alities in the metabolism o f
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la c ta te , pyruvate, alanine, g lycero l and ketone bodies than phenform in 
and buform in at doses tha t have equal hypoglycaemic potency (Nattrass 
e t al., 1977; Czyzky et a l., 1978). However, i t  is more like ly  tha t risk o f 
la c tic  acidosis is re lated to d ifferences in the ra te  o f metabolism and/or 
excretion o f individual biguanides (1.1); m etform in-induced la c tic  
acidosis is associated only w ith  pre-existing renal insuffic iency since the 
drug is excreted predom inantly unchanged by the kidney (Hermann, 
1981). A lte red renal function may be im portant in the to x ic ity  o f a ll 
biguanides: o f 330 reported cases o f biguanide-associated la c tic  acidosis 
reviewed by L u ft e t al., (1978), 285 patients had received phenform in, 9 
buform in and 16 m etfo rm in ; only 8 patients had normal plasma 
creatin ine at the tim e o f diagnosis. The rate at which phenform in is 
hydroxylated by the liv e r is an im portant determ inant o f blood 
phenform in concentration (Bosisio e t ^ . ,  1981), consequently liv e r 
function may be o f more importance in pre-disposition to phenform in- 
to x ic ity  than renal insu ffic iency. Genetic im pairm ent o f phenform in 
metabolism has been mentioned (1.1); diabetes may fu rthe r influence 
drug metabolism (Past and Cook, 1982). Factors which may cause a 
predisposition towards biguanide-associated la c tic  acidosis are lis ted in 
Table 1.3; these conditions may contribu te  to the development o f la c tic  
acidosis by im pairm ent o f hepatic and renal mechanisms of drug disposal 
and/or because they lead to lacta te  accumulation through inh ib ition  o f 
ce llu la r respiration or tissue ischaemia.
The signs and symptoms of biguanide-associated la c tic  acidosis are
not specific but include epigastric pain, nausea, vom iting, le thargy,
somnolence, diarrhoea and hyperpnoea; hypotherm ia may be evident in a
number o f patients (Kreisberg and Wood, 1983). The m etabolic 
s
derangement actua lly  a mixed la c tic  and ketoacidosis (Fulop and 
Hoberman, 1976), a fa c to r which has c lin ica l im plications w ith  regard to
-  8 -
TABLE 1.3 FACTORS WHICH M AY CAUSE A  PREDISPOSITION TOWARDS 
BIGUANIDE-ASSOCIATED LA C TIC  ACIDOSIS
1. Renal insu ffic iency; d iabetic nephropathy.
2. Hepatic fa ilu re ; alcoholism .
3. Cardiovascular disease w ith  c ircu la to ry  im pairm ent; severe diabetic 
angiopathy.
4. Respiratory disease; conditions leading to tissue hypoxia; severe 
hypertension.
5. D iabetic ketoacidosis.
6. Acute severe in fections or trauma.
7. Simultaneous use o f drugs which may in h ib it ce llu la r respiration or 
lower tissue oxygenation.
8. Before operations under general anaesthesia.
Abstracted from  Schafer (1983)
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therapy (Halperin, 1977).
Treatm ent o f biguanide-associated la c tic  acidosis has been largely 
unsuccessful w ith  m o rta lity  rates o f about 50% (A lbe rti and Nattrass, 
1977). Uncontro lled studies have suggested tha t the m o rta lity  ra te  can 
be lowered by the use o f insulin and glucose (Dembo e t ^ . ,  1975; M isbin, 
1977) although this finding has recently been questioned (Cohen and lies, 
1980). Most authors agree th a t in severe la c tic  acidosis due to biguanide 
therapy, a rte ria l pH should be restored to normal w ith in  a few  hours 
using sodium bicarbonate (Cohen and lies, 1980). D ich loroacetate , a 
powerfu l ac tiva to r o f pyruvate dehydrogenase (Whitehouse and Randle, 
1973; Whitehouse et ^ . ,  1974), was shown to decrease blood lac ta te  
concentrations in starved and diabetic rats (Blackshear et al.,: 1974; 
1975); although dichloroacetate could prevent (Holloway and A lb e rti, 
1975) or reverse (Holloway and A lb e rti, 1977) phenform in-induced 
hyperlactataem ia in experim ental animals, i t  has had only lim ite d  
success in the trea tm ent o f biguanide-associated c lin ica l la c tic  acidosis 
since the compound is its e lf tox ic  at high doses (Irsig ler et W., 1977).
1.3 MECHANISM OF TOXICITY
1.3.1 M etabolic basis
The pharmacodynamics o f biguanide therapy have been outlined in 
Table 1.2; the mechanism o f to x ic ity  may be considered as an extension 
o f therapeutic action, pa rticu la rly  enhanced peripheral anaerobic 
glycolysis and inh ib ition  o f hepatic and renal gluconeogenesis, a t high 
drug concentrations.
K ine tic  studies o f lac ta te  metabolism in man revealed both 
inh ib ition  o f lacta te  u tilisa tio n  (oxidation) and increased production 
(Searle and Siperstein, 1975). In healthy volounteers buform in increased 
glucose u tilisa tion  and its  conversion to lac ta te  by the extrahepatic
- 10 -
splanchnic bed (gastro in testina l tra c t)  (Bratusch-M arrain e t al., 1981); 
D ietze et W., (1978) showed tha t the hepatic clearance o f lacta te  and 
the production o f glucose are reduced in non-diabetjc volounteers 
receiving phenform in a t therapeutic doses. Bratusch-Marrain e t al., 
(1981) fu rthe r reported tha t lacta te  concentrations in hepatic and porta l 
venous blood were increased w ith  buform in, whereas the concentration in 
the fem oral vein was unaltered; Kreisberg and Wood (1983) have 
concluded tha t hyperlactataem ia may be due to changes in splanchnic 
lacta te  metabolism and not increased lac ta te  production by skeleta l 
muscle. S im ila rily , A r ie f f  et ^ . ,  (1980) showed tha t extrahepatic 
splanchnic lac ta te  production was increased, and hepatic uptake reduced, 
in phenform in-treated dogs; a corresponding depression in lac ta te  uptake 
was absent in animals infused w ith  su ffic ien t la c tic  acid to produce a 
degree of acidosis s im ila r to those treated w ith  phenform in. Animals 
receiving the drug had a s ign ifican tly  lowered hepatic ce ll pH compared 
to dogs receiving la c tic  acid; A r ie f f  and his colleagues a ttribu ted  
depression o f lacta te  uptake to the low in trace llu la r pH, and to the 
substantial reduction in blood flow  through the porta l vein observed 
during the adm in istra tion o f phenform in. L loyd e t ^ . ,  (1973) have shown 
tha t the uptake o f lacta te  is decreased in isolated perfused ra t liv e r 
when the in trace llu la r pH fa lls  below pH 7.1; decreased lac ta te  
consumption and glucose output were both associated w ith  a fa ll in 
in trace llu la r pH in isolated perfused guinea-pig live r (Lloyd e t a l., 1975).
A fte r  oral adm in istra tion o f ] phenform in in the ra t, much
o f the label remained in the stomach and intestines (Wick e t W., 1960); 
phenform in may inh ib it the in testina l absorption o f a number o f sm all 
molecules (Table 1.2). I t  has been suggested tha t the e ffe c ts  o f 
phenform in on the gut derive from  an inh ib ition  o f m itochondria l 
oxidative-phosphorylation (Nicholls and Leese, 1984); vascular perfusion
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o f the ra t small in testine w ith  phenform in resulted in a concentration 
dependent decrease in mucosal ATP content and an 88% decrease in 
glucose uptake from  the vascular medium (at 5mM phenform in), 97% o f 
which could be accounted fo r by lac ta te  form ation . These results suggest 
tha t the in testine may be a s ign ifican t source o f lacta te  production in 
la c tic  acidosis.
1.3.2 B iochemical basis
Inh ib ition  o f ce llu la r respiration by alkyl-guanidines was f irs t  
observed by Hollunger (1955). The earliest theories o f biguanide action in 
vivo proposed tha t the fa ll in blood glucose arose from  an increase in 
peripheral anaerobic glycolysis producting lacta te , and an inh ib ition  o f 
aerobic ce llu la r respiration (Tyberghein and W illiams, 1957; Steiner and 
W illiams, 1958); under these conditions glycolysis acts as a se lf- 
contained m etabolic cycle in which pyruvate becomes the oxidant fo r 
NADH produced in the oxidation o f glyceraldehyde-3-phosphate to 1,3- 
diphosphoglycerate (glyceraldehyde-3-phosphate dehydrogenase, [1  ]); 
one turn  o f the cycle produces only two molecules ATP/m olecule glucose 
from  substrate-level phosphorylation (phosphoglycerate kinase, [2 ] ).
Glyceraldehyde-3-phosphate + NAD^ + P. 4 .
1,3-Diphosphoglycerate + NADH + H^ [1 ]
1,3-Diphosphoglycerate + ADP-4— ►3-Phosphoglycerate + ATP [2 ]
An inh ib ito ry  locus o f in terference w ith  aerobic respiration (Figure
1.2) has been variously ascribed as inh ib ition  o f NADH oxidation
- 12 -
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Figure 1.2. FLOW-SHEET OF AEROBIC RESPIRATION.
In h ib it io n  o f aerobic re sp ira tio n  re su lts  in  s tim u la tion  o f anaerobic 
g lyco lys is  and lac ta te  formation (thickened arrows).
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(Ogata et al., 1974; Evans et al., 1983), succinate oxidation (Steiner and 
W illiams, 1958; Wick et al., 1958; Pressman, 1963) and o f m itochondria l 
NAD^-dependent dehydrogenase reactions (Ungar et 1960; Evans e t 
al., 1983). In addition to any s ite -specific  e ffects , biguanides inh ib it 
proton movements during oxidative-phosphorylation in isolated 
m itochondria (Schafer and Rowohl-Quisthoudt, 1975; Schafer e t ^ . ,
1974).
An inh ib ito ry  e ffe c t o f phenform in on gluconeogenesis was 
suggested by experiments in v itro  which showed impaired glucose 
production and ATP depletion in ra t kidney tissue slices (P a trick , 1966) 
and in isolated perfused guinea-pig live r (A ltshuld and Kruger, 1968). 
Haeckel and Haeckel (1972) were the f irs t  to demonstrate an association 
between a sh ift in the m itochondria l oxidation-reduction state towards 
reduction and inh ib ition o f hepatic gluconeogenesis by phenform in. 
N A D H /N AD ^ and ATP/ADP ratios are inversely re la ted via the 
resp ira tory chain: decreased ATP/ADP and increased N A D H /N AD ^ 
ratios are consistent w ith  the view tha t inh ib ition o f gluconeogenesis is 
secondary to inh ib ition o f respiration and impaired ox ida tive- 
phosphorylation since ATP is required in the gluconeogenic pathway fo r 
the carboxylation o f pyruvate (pyruvate carboxylase, [3 ] ), and the 
form ation o f phosphoenolpyruvate from  oxaloacetate (phosphoenol- 
pyruvate carboxykinase, [4 ] ).
Pyruvate + COg + ATP — ►Oxaloacetate + ADP + P. [3 ]
Oxaloacetate + (ATP) — ► Phosphoenolpyruvate +
COg + (ADP) + p. L4]
Gluconeogenesis from  alanine is especially sensitive to  inh ib ition
- 14 -
by phenform in (Ogata et a l., 1974) since net synthesis o f 2-oxoglutarate 
from  glutam ate (glutam ate dehydrogenase, [5J ) is unfavorable at high 
N A D H /N AD ’’’ ra tios and hence less available fo r transam ination (alanine 
transaminase, [6 ] ).
G lutam ate + NAD^ , ► 2-Oxoglutarate + L5]
+ HgO +NADH
Alanine + 2-Oxogiutarate 4-.........   ► Pyruvate + G lutam ate [6 ]
Cook et ^ . ,  (1973) have concluded tha t phenform in has no d irec t 
e ffe c t on the enzymes of the gluconeogenic pathway but suggest the 
possib ility  tha t phenform in may a lte r in trace llu la r conditions in some 
way as to become an e ffe c tive  inh ib ito r o f one or more gluconeogenic 
enzymes. Cook et ^ . ,  (1973) have fu rthe r suggested tha t although 
phenform in causes a reduction in trica rb oxy lic  acid cycle a c tiv ity  and a 
decreased ATP/ADP ra tio  in isolated perfused ra t live r, inh ib ition  o f 
gluconeogenesis is not d irec tly  related to the energy-requirements o f the 
process but involves impaired m itochondria l function. From comparisons 
o f the e ffe c t o f phenform in on gluconeogenesis in isolated perfused 
livers from  normal, fed and alloxan-d iabetic rats. Cook (1978) has shown 
tha t although phenform in can reduce the elevated ra te  o f 
gluconeogenesis in d iabetic ra t live r, reduction to the slower ra te  o f 
normal, fed controls occurs only a t concentrations which a ffe c t other 
m etabolic parameters such as substrate uptake, CO g production, and 
ce llu la r redox ratios. Cook (1978) has in terpre ted these results to suggest 
tha t i f  phenform in acts as an an ti-d iabe tic  agent at least in pa rt by 
inh ib ition  o f hepatic gluconeogenesis, then a meaningful reduction in 
gluconeogenic a c tiv ity  to normal levels occurs only in concert w ith
- 15 -
inh ib ition of other hepatic processes which have previously been 
considered a ffected  only at high, non-therapeutic doses.
1.3.3 Molecular basis
Despite an apparent m u lti-s ite  action of biguanides on metabolic 
function (1.3.1), the concept o f an underlying mechanism at the 
molecular level has been addressed by Schafer (1976a, 1980): 
Investigation o f various energy-linked or respiration-linked functions 
suggest that the m etabolic e ffects  in general could be a ttribu ted  to 
inh ib ition o f energy conservation, e ither d irec tly  or ind irec tly  (1.3.2); 
furtherm ore, it  is apparent tha t biguanides act only on biological 
processes associated w ith  membranes (Shafer, 1980), and on 
m itochondrial membranes in particu la r, but are ine ffec tive  against 
isolated soluble enzymes. Schafer and his co-workers (Schafer and 
Bojanowski, 1972; Schafer et ^ . ,  1972; Schafer, 1974a; Schafer 1974b; 
Schafer et al., 1974; Schafer, 1976a; Schafer, 1980) have proposed that 
membrane structure is the prim ary site of in teraction w ith  biguanides 
and that physicochemical a lte ra tion  in structure may modulate 
m itochondrial function.
From evaluation o f pK values (e.g. for phenform in pK^, 11.8; pK^, 
2.7: Elpern, 1968) i t  can be concluded tha t under physiological conditions 
biguanides exist in solution as mono-protonated species. The m olecular 
structure o f protonated biguanides is that o f resonance stabilised 
cations, as deduced from  spectroscopic data (Shapiro et al., 1959; 
Fanshawe et a l., 1964):
♦
R -N H .-C  C -N H , R -N H .-C  Ç -N H ,
II I    I II
HN^ NH "  HN^ ,NH
^  \  * 
R -N H -C  C -N H ,   R -N H -C  C -N H
IN
'H '  H
H N . H H N ^  ,NH
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Biguanides bind f irm ly  to m itochondria l (and other) membranes 
(Schafer and Bojanowski, 1972); good corre la tion o f binding a ffin it ie s  
w ith  p a rtition  coe ffic ien ts  in n-octanoi/phosphate buffer, indicates tha t 
there is almost no e lec tros ta tic  contribu tion  to binding and th a t the 
in te raction  is exclusively hydrophobic. I t  may be concluded tha t 
molecules o f alkyl-biguanide tend to adsorb to membrane in terfaces by 
means of the hydrophobic side-chain, w ith  the hydrocarbon m oiety 
oriented towards the hydrophobic phase and the guanidinium cation 
exposed to the aqueous phase; the positive ly charged ion must therefore  
be considered the active portion o f the molecule. The close s im ila r ity  o f 
binding to synthetic phospholipid vesicles and m itochondrial membranes 
suggest tha t membrane phospholipids are the binding sites fo r both 
guanidines and biguanides (Schafer, 1974a; 1974b).
Studies on the conductance o f phospholipid bilayers show th a t 
binding o f biguanides is associated w ith  a positive sh ift in membrane 
surface potentia l due to the contribu tion o f f irm ly  fixed positive charge, 
by guanidinium cations (Schafer 1974b; Schafer e t al., 1974). Generation 
o f a positive s h ift in m itochondria l inner membrane potentia l due to 
in te raction  w ith  biguanide is associated w ith  concentration-dependent 
inh ib ition  o f oxidative phosphorylation (Schafer and Rowohl-Quisthoudt,
1975) and may explain the metabolic e ffec ts  o f phenform in and o ther 
hypoglycaemic biguanides in vivo (Schafer, 1980), (Figure 1.3). The low 
binding a ff in ity  o f 4-hydroxyphenform in compared to unchanged drug, 
corre lates w ith  a lowered inh ib ito ry  action on m itochondria l oxidative  
phosphorylation and weak an ti-d iabe tic  a c tiv ity  in vivo (Schafer, 1976b).
Schafer (1976b) has shown tha t there exists a d irec t in te rac tion  
between biguanides and the m igration o f cations across the inner 
m itochondria l membrane; in pa rticu la r, modulation o f surface charge by 
n-octylbiguanide caused a reduction in the ra te  constant o f Ca^^ uptake
- 17 -
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although the am plitude o f uptake was unaltered. Inh ib ition o f Ca^^ 
uptake is o f especial in te rest since this cation is o f potentia l importance 
in the regulation o f oxidative metabolism in mammalian m itochondria 
via the ac tiva tion  o f pyruvate, isoc itra te  and 2-oxoglutarate 
dehydrogenases (Denton e t al., 1978). Evans e t al., (1983) have recently 
suggested tha t inh ib ition  o f NAD^-dependent m itochondrial 
dehydrogenases may be involved in the im pairm ent o f gluconeogenesis by 
phenform in.
1.4 EXPERIMENTAL RATIONALE
The main feature o f the curren tly  accepted mechanism of 
biguanide action (Schafer, 1980) is an a lte ra tion  in net surface charge 
and/or charge d is tribu tion  o f biological membranes by hydrophobic 
fixa tion  o f guanidinium cations. This model implies an a lte ra tion  in ion 
flux  and m etabolite  d is tribu tion  between cytosol and m itochondria as a 
result o f the changes in m itochondria l proton gradient and membrane 
potentia l which d irec tly  a ffe c t ATP production. Cook e t a l., (1973) have 
concluded tha t inh ib ition  o f gluconeogenesis is not d irec tly  re lated to the 
energy-requirements o f the process but involves im pairm ent o f 
m itochondria l function. The objective o f this thesis was to test the 
hypothesis tha t the hypoglycaemic and hyperlactataem ic e ffec ts  o f 
phenform in (3-phenethylbiguanide) may be a ttribu tab le  to im paired ATP 
production arising from  inactiva tion  o f Ca^^-sensitive, NAD^-dependent 
m itochondria l dehydrogenases due to a lte ra tion  in m itochondria l calcium  
content by in te raction  o f the drug w ith  m itochondria l membranes.
CHAPTER TWO •
INTERACTION OF PHENFORMIN WITH MITOCHONDRIA AND 
SUB-MITOCHONDRIAL PARTICLES
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2.1 INTRODUCTION
The mechanism o f biochem ical action o f phenform in in 
m itochondria remains uncertain; a review of the sc ie n tific  lite ra tu re  
reveals confusing and often con flic ting  views based upon experiments in 
v itro . In it ia l investigations were conducted in order to  c la r ify , 
consolidate or substantiate the results of earlie r workers.
Previous work in th is laboratory (Evans e t al., 1983) has shown tha t 
succinate, and to a lesser extent, m alate, prevented the development o f 
the marked hypoglycaemia and associated hyperlactataem ia norm ally 
caused by phenform in in starved rats. These results suggest tha t
succinate is able to maintain m itochondria l energy production both via 
flavin-dependent succinate dehydrogenase and malate dehydrogenase.
M o rta lity  in phenform in-associated la c tic  acidosis is about 50% 
(A lb e rti and Nattrass, 1977); trea tm ent usually involves alka lin isation 
w ith  bicarbonate, the use o f dichloroacetate having been curta iled  due to 
its  to x ic ity  (Moore et a l., 1979) and m utagenic ity (Herbert e t al., 1980). 
Succinate may be useful in the reversal o f c lin ica l la c tic  acidosis 
fo llow ing biguanide therapy, since its  to x ic ity  is like ly  to be very low. 
The antidote e fficacy  o f disodium succinate, fo llow ing phenform in 
in tox ica tion , was investigated in m ice.
In  studies have suggested tha t biguanides act only on
membrane-bound systems but are ine ffec tive  against isolated soluble 
enzymes. The close s im ila r ity  o f binding to synthetic phospholipid 
vesicles and m itochondrial membranes suggests tha t membrane 
phospholipids are the binding sites fo r both guanidines and biguanides 
(Schafer, 1974a; Schafer, 1974b). Studies w ith^^C -labe lled  biguanides 
have also shown that upon energisation of m itochondria, biguanides can 
permeate the membrane (Schafer e t W., 1972; Schafer and 
Bojanowski, 1969) and accumulate inside, although the permeation
- 20 -
process is ra ther slow. The accumulated biguanides are osm otically 
inactive and do not cause swelling: this would suggest tha t they do not 
exist as free cations but ra ther adhere to the membrane surface through 
hydrophobic binding to membrane lipids (D avidoff, 1977). I t  has been 
proposed tha t the membrane structure its e lf is the prim ary site o f 
in te raction  and tha t physicochemical a lte ra tion  o f structure  and function 
may modulate the c a ta ly tic  properties of membrane proteins 
(Schafer, 1980).
D isruption o f m itochondria l preparations w ith  high concentrations 
o f phosphate and ethanol causes fragm entation into membranous vesicles 
(subm itochondrial partic les; e lectron transport partic les) (Green and 
Z iegler, 1958); these fragments as recovered by d iffe re n tia l 
centrifugation , are e ffe c tive ly  pieces o f inner m itochondria l membrane.
The partic les lack ATP synthetase a c tiv ity  and are com plete ly 
uncoupled. In the course o f preparation, free or loosely-bound enzymes 
and co -fac to rs  are removed: the enzymes of the resp ira tory chain and 
energy transducing processes are reta ined (Lee and Storey, 1981). The 
partic les have inverted membrane orien ta tion re la tive  to in ta c t 
m itochondria (Figure 2.1): membrane-bound enzymes o rig ina lly
in te racting  w ith  components in the m atrix  space are free ly  accessible to 
solutes in the suspending medium.
Submitochondrial partic les, as prepared from  guinea-pig and ra t 
live r, constitu te  a simple and convenient experimental system fo r the 
study o f resp ira tion-linked reactions and were used to  investigate the 
e ffec ts  o f phenform in, 4-hydroxyphenform in and m etfo rm in  on NADH 
dehydrogenase (Complex I; NADH-ubiquinone oxidoreductase) and 
succinate dehydrogenase (Complex II; succinate-ubiquinone oxidoreductase).
The presence o f Ca^^ decreased the fo r the oxidation o f both 
th re o -D g-isoc itra te  and 2-oxoglutarate in uncoupled m itochondria from
- 21 -
C-FACE Cyt. b
c y t. a
cy t. a
INNER MITOCHONDRIAL MEMBRANE
M-FACE
F igure  2.1 Schematic diagram o f the topog rap h ic
re la t io n s h ip  between components o f the 
re s p ira to ry  cha in
( a f t e r  W h itta k e r & Danks, 1973)
( I )  Complex I ;  NADH-ubiquinone oxidoreductase
( I I )  Complex I I ;  Succinate-ubiquinone oxidoreductase
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brown adipose tissue of cold-adapted rats (McCormack and 
Denton, 1980). In coupled heart m itochondria incubated w ith  ADP, 
increases in the ex tra -m itochondria l concentration o f Ca^"^ greatly  
stim ulated 2-oxoglutarate oxidation a t low concentrations (Denton et 
al., 1980). D av ido ff and Haas (1979) found tha t a low concentration o f 
phenform in, added in v it ro , s ign ifican tly  decreased the Ca^"^ content o f 
hepatic m itochondria from  fasted, but not fed, guinea-pigs. Experiments 
were designed to investigate the e ffe c t o f phenform in on isolated 
(coupled) ra t hepatic m itochondria (incubated w ith  succinate and 
2-oxoglutara te) in d iffe re n t concentrations o f ex tra -m itochondria l Ca^'*’ . 
The e ffe c t o f exposure to phenform in during isolation o f m itochondria, 
on m itochondria l Ca^^ content, was determined using the livers of 
contro l, fed guinea-pigs, rats and hamsters.
2.2 MATERIALS AND METHODS
2.2.1 Chemicals
Phenform in hydrochloride and 4-hydroxy-phenform in hydrochloride 
were donated by S terling-W inthrop Research Laboratories, A lnw ick, 
Northumberland, England. M etfo rm in  hydrochloride was a g if t  from  
Rona Laboratories L td ., H itch in , H ertfo rdsh ire , England.
8 -Anilino-naphthalene 1-sulphonic acid (ANS), NADH, sodium 
m alate, disodium succinate and 2-oxoglutara te (mono-potassium salt) 
were obtained from  Sigma (London) Chemical Co. L td ., Poole, Dorset, 
England. Before use, 2-oxoglutarate solution (4 M) was neutralised w ith  
4 M potassium hydroxide.
A ll other chemicals were obtained from  B ritish  Drug Houses L td ., 
Poole, Dorset, England or from  Sigma, and were generally o f analar 
grade.
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2.2.2 Animals and Adm in is tra tion  o f Compounds
A du lt male animals were used in most experiments; a ll animals 
were allowed food and water ^  lib itu m .
W istar albino rats (approximately 250 g) were from  a derived stra in 
(University o f Surrey); D unkin -H artley albino guinea-pigs (approximately 
300 g) were obtained from  Graystone Guinea-pigs, Ringwood, Hampshire, 
England; Golden Syrian hamsters (approximately 100 g) were supplied by 
Wrights o f Essex, Chelmsford, Essex, England; CD I-outbred (P irbright) 
m ice (approxim ately 35 g) were purchased from  the Anim al Virus 
Research Ins titu te , P irb righ t, Surrey, England.
(i) E ffe c t o f Disodium Succinate on Phenform in Hydrochloride In tox ica tion  
in Mice
Phenform in.HCl was dissolved in saline (0.9%, w /v) such tha t the 
volume given by in traperitonea l in jection was approxim ately 0.1 m l. The 
pH o f the solution was adjusted to 6 -  6.5 w ith  1 M sodium hydroxide. 
Dosing was in the range 100 - 150 mg/kg body weight.
Disodium succinate was dissolved in d is tilled  water such tha t the 
volume received by oral garage was approxim ately 0.2 m l. The dose was 
2 mmol/kg body weight.
2.2.3 Isolation o f M itochondria
Isolation o f m itochondria was based upon the procedure o f ChappelÀ 
and Hansford (1972). M itochondria prepared by this method have been 
shown to have high respiratory contro l ratios (Reeve, 1981).
L ivers were removed as rapid ly as possible and rinsed in iso lation 
medium (ice-co ld  0.25 M sucrose, pH 7.4 a t 2G°C, containing various 
additions). Tissues were scissor-minced in fresh medium (2.5 m l/g  
orig ina l tissue), forced through a p lastic mesh and homogenised (6 passes)
- 24 -
using a manually operated Bounce homogeniser w ith  a loose f it t in g  
pestle (clearance < 0.005").
D ilu ted homogenates (approximately 60 m l, to ta l volume) were 
centrifuged at 1,000 g (Beckman J2-21, 14 x 50 ml fixed angle ro to r 
pre-cooled to 4°C ; 2,750 r.p.m .) fo r 10 m in. Pellets were discarded and 
the supernatants were centrifuged at 10,000 g (8,500 r.p.m .) fo r 10 min. 
Resulting pellets were gently re-suspended (2 m l/g  orig ina l tissue) by 
s tirring  w ith  a glass rod, and then re-sedim ented a t 10,000 g fo r 10 min.
Washed m itochondria l fractions were care fu lly  resuspended 
(0.5 m l/g  orig ina l tissue) in 0.25 M sucrose, 3.4 mM Tris HC l, pH 7.4 
(enzyme studies) or de-ionised water (determ ination o f m itochondria l 
Ca^^). U n iform  resuspension was obtained by gentle s tirring  w ith  a 
small magnetic flea.
2.2.4 Isolation o f Sub-m itochondrial Particles
Sub-m itochondrial partic les from  ra t and guinea-pig liv e r were 
prepared by a method adapted from  Green and Z iegler (1958) fo r the 
isolation o f partic les from  beef heart.
Animals were k illed  by cerv ica l d islocation and the livers rapid ly 
excised, pooled, rinsed in ice -co ld  medium (0.25 M sucrose, 10 mM 
Tris HCl bu ffe r, pH 7.6 containing 1 mM disodium EDTA), homogenised 
in a pre-cooled W aring-blender to give a 40% (w /v) suspension and 
centrifuged at 1,000 g (Beckman J6, pre-cooled; 2,200 r.p.m .) fo r 6 m in. 
The pe lle t was discarded and the supernatant centrifuged at 15,000 g 
(Beckman J2-21, pre-cooled JA14 ro to r; 12,500 r.p .m .) fo r 15 min.
The pe lle t was resuspended (Polytron tissue homogeniser) in 
approxim ately 400 ml ice -co ld  medium, centrifuged at 20,000 g 
(Beckman J2-21, pre-cooled JA17 ro to r; 14,000 r.p.m .) fo r 15 m in. The 
resulting pelle t was resuspended in 5 volumes o f medium and the
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phosphate concentration adjusted to 0.15 M w ith  1.0 M phosphate bu ffe r, 
pH 7.6. Cold (-10°C ) 95% ethanol was added (slowly, w ith  m ixing) to a 
fina l concentration of 15% (v/v); the suspension was thoroughly mixed 
(Polytron) and centrifuged at 15,000 g fo r 15 min. The supernatant was 
decanted and centrifuged at 105,000 g fo r 50 min. (Beckman LS-65B, 
pre-cooled 60 T i ro to r; 50,000 r.p.m .) and the deep red pe lle t 
resuspended in approxim ately 4 volumes ice -co ld  medium. The 
preparation was stored in 2 m l aliquots at -20°C  un til use.
2.2.5 Determ ination o f 8-Anilinonaphthalene 1-Sulphonic Acid (ANS) Binding
Binding o f phenform in to  m itochondria and sub-m itochondria l 
partic les was measured by the method o f Schafer ( 1974a ) using the 
fluorescent probe, 8-anilinonaphthlene 1-sulphonic acid (ANS).
A liquots o f m itochondrial frac tion  or sub-m itochondria l partic les 
(3 mg prote in) were incubated w ith  phenform in HC l ( 0 - 5  mM) fo r 
15 m in. at 20°C. Incubations (to ta l volume, 1.0 m l) were carried out in 
polypropylene m icro -cen trifuge  tubes.
Incubation medium:
0.25 M sucrose
0.02 M Tris HC l, pH 7.2
30 mM a n s
Reactions were term inated by centrifug ing at 1,000 r.p.m . fo r 
2 m in. in an MSE M icro-centaur centrifuge. Samples o f the supernatant 
(0.1 m l) were transferred to p lastic tubes containing 3.9 m l o f solution 
comprising 0.25 M sucrose, 0.02 M Tris H C l, pH 7.2 and 0.5% BSA.
ANS im m ediate ly binds to the serum albumin producing a 
concom itant increase in fluorescence (Figure 2.2).
Fluorescence o f samples was measured in p lastic disposable 
cuvettes using a Perkin-E lm er LS-5, luminescence spectrom eter
( = 390 nm; x = 480 nm).ex em
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2.2.6 Measurement of Oxygen Uptake
Rates o f respiration o f in ta c t m itochondria and sub-m itochondria l 
partic les were recorded using a C la rk-type  oxygen electrode (Rank 
Brothers, Bottisham, Cambridge, England).
C a libra tion o f the electrode was carried out da ily, using 
sub-m itochondria l partic les derived from  ra t live r. Sub-m itochondrial 
partic les readily oxidise NADH. Addition o f 10 pi aliquots o f 10 mM 
NADH to incubation medium containing sub-m itochondrial partic les 
(7 -  8 mg protein) gave an average daily deflection x (m illim e tres chart 
paper), equivalent to 0.1 pmol NADH:
i.e. X (mm) = 0.1 x 10” ^ mol NADH
Since 1 mol = 2 mol NADH 
1 mm chart deflection = 0.03 x 10~^ mol O2
For determ ination o f succinate and NADH dehydrogenase a c tiv ity  in 
sub-m itochondria l partic les, a ll incubations were carried out a t 23°C; 
each incubation contained approxim ately 7 - 20 mg prote in in a to ta l 
reaction volume of 2 ml bu ffe r (0.1 M potassium phosphate, pH 7.5 
containing 10“ ^ M disodium EDTA). Phenform in HC l,
<X4\ct HCA. f
4-hydroxyphenform in H C j{ NADH and succinate (disodium salt), were 
prepared in the phosphate bu ffe r such tha t 0.2 m l and 10 pi, 
respective ly, gave the indicated concentration in 2 m l. Partic les were 
pre-incubated in bu ffe r, w ith  or w ithou t biguanide, at 25°C fo r 5 m in. 
Reactions were started by the addition o f substrate. The M ichaelis 
constant, K ^ ,  was determined fo r each enzyme; a convenient substrate 
concentration was chosen fo r each inh ib ition  study and is indicated below 
the appropriate table.
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SUBSTRATE
ADP
ADP
APPARENT STATE I I I
R E S P IR A T IO N  ( I I I )
STATE I V
R E S P IR A T IO N  ( I V )
DECREASING  
Op CONCENTRATION
T IM E
Figure 2.3 Typical trace o f O^-electrode recording
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Succinate and 2-oxoglutarate dehydrogenase ac tiv itie s  were 
determined in isolated ra t hepatic m itochondria. A ll incubations were 
carried out at 25°C; each incubation contained 5 - 1 0  mg m itochondria l 
prote in in a to ta l volume o f 2 ml o f incubation medium:
Incubation medium
40 mM HEPES bu ffe r, pH 7.4 
120 mM HCl 
8 mM MgClp
10 mM potassium phosphate bu ffe r, pH 7.4 
5 mM EGTA or 5 mM EGTA/2 mM CaClp were included in the incubation 
medium where indicated. Substrates, disodium succinate and 
2-oxoglutara te (monopotassium salt) were prepared in incubation 
medium such tha t addition of 10 pi gave the indicated concentration in 
2 m l; 1 mM malate was also present in determ inations o f oxoglutarate 
dehydrogenase a c tiv ity . M itochondria were pre-incubated w ith  bu ffe r, 
w ith  or w ithou t phenform in, fo r at least 5 min. Reactions were started 
by the addition o f substrate (State IV respiration), and 0.5 pmol ADP 
(apparent State III). A typ ica l chart recording is shown in Figure 2.3. 
True State III respiration is determined as (III) - (IV).
2.2.7 Measurement o f Ca^^
M itochondria l Ca^^ was determ ined by the method o f McDonald et 
al., (1976).
A ll m itochondrial preparations were frozen in sterilised p lastic  
tubes prio r to analysis. A liquots (1.0 m l) were solubilised w ith  
10 M NaOH and heated in a water bath at 75°C, fo r aproxim ately 5 m in; 
1.0 m l o f a solution containing 0.01 M lanthanum chloride, 0.025 M HC l,
0.02 M EDTA and 0.08 M NaOH was added and the samples again heated
1
fo r 5 m in. The m ixture  containing lanthanum chloride was prepared in a 
vo lum etric  flask which had been washed in concentrated HC l overnight.
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followed by 10 rinses w ith  de-ionised water. A ll b iological samples were 
trea ted in sterilised p lastic tubes so as to minimise contam ination from  
extraneous Ca^"*". Appropriate reagent blanks were run in paralle l.
Samples were analysed fo r Ca^^ by atom ic absorption spectroscopy 
(In ternational Laboratories, 1L3 spectrophotometer) on the day o f assay.
2.2.8 Measurement o f Protein
Protein was determ ined by the method of Lowry e t al., (1951).
2.2.9 Analysis o f Data
S ta tis tica l analysis are presented under the appropriate Figure or 
Table. The s ta tis tica l significance o f d ifferences found between groups 
was assessed using Student's t - te s t.
2.3 RESULTS
2.3.1 E ffe c t o f Disodium Succinate on Phenform in In toxication in Mice
The mouse, although pa rticu la rly  resistant to the hypoglycaemic 
e ffec ts  o f phenform in (Sterne, 1969), was chosen as the experim ental 
model in which to test the e fficacy  o f disodium succinate in the reversal 
o f biguanide-induced la c tic  acidosis: test compounds may be read ily  
administered by both oral and in traperitoneal routes; mice are easily 
managed in the re la tive ly  large numbers required in a study where the 
incidence o f m o rta lity  is the single measured parameter.
P re lim inary dose-ranging experiments suggested tha t 
phenform in HC l (250 mg/kg, i.p.) given in two separate doses caused 
death a ttribu tab le  to la c tic  acidosis. A single dose in excess o f 
150 mg/kg (males) or 125 mg/kg (females) was not to lera ted by the 
animals and resulted in death, preceded by convulsions, w ith in  1 m in o f 
adm in istra tion. In order tha t su ffic ie n t numbers survived this acute
- 31 -
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to x ic ity , 40 male and 40 female CD I-m ice received phenform in HCl 
(2 X 125 mg/kg, i.p.) w ith  i j  hours between doses: the number o f animals 
tha t died before the second dose (3 male, 6 female) or w ith in  30 min o f 
the second dose (13 male, 13 female) were a ttribu ted  as ’acute deaths’. 
Death was preceded by convulsions in every case; surviving animals a il 
exhibited d is tinc t c lin ica l signs o f hypoglycaemia (lethargy, splayed hind 
limbs and tremors).
Survivors were randomly assigned to contro l and tes t groups 
(Table 2.1); 2 male and 6 female animals died soon a fte r  receiving 
disodium succinate by oral gavage. Deaths occurring more than 3 h 
fo llow ing in it ia l trea tm ent w ith  phenform in were a ttribu ted  to  la c tic  
acidosis; the incidence o f m o rta lity  in male (82%) and female (88%) 
controls (phenformin only) was markedly greater than in male and female 
animals receiving disodium succinate (36% and 57% respective ly).
There were a number o f la te deaths (< 48 hours a fte r dosing) a fte r  
which a ll surviving animals appeared healthy. The to ta l number o f 
deaths were as fo llow s:-
Group 1 - 11 deaths from  11 animals (100%)
Group 2 - 5 deaths from  11 animals (46%)
Group 3 - 8 deaths from  8 animals (100%)
Group 4 - 5 deaths from  7 animals (71%)
2.3.2 Comparison o f the E ffects  o f Phenform in, 4-Hydroxyphenform in and 
M etfo rm in  on NADH-Ubiquinone Oxidoreductase and Succinate- 
Ubiquinone Oxidoreductase in Sub-M itochondrial Partic les
Binding o f 8-anilinonaphthalene 1-sulphonic acid (ANS) to  pro te in  
causes a concom ittant increase in its  fluorescence; fluorescence
-  33 -
Figure 2.4 INFLUENCE OF PHENFORMIN ON BINDING OF ANS TO RAT AND
GUINEA-PIG SUB-MITOCHONDRIAL PARTICLES
(a)
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- 1
Hepatic sub-mitochondrial p a rtic le s  were iso la ted  from Wistar a lb ino ra t (a) 
and guinea-pig ( a ) .  P artic les  were incubated w ith 0 - 5 mM phenformin HCl 
and 30 pM ANS.
(a) Decrease in  ANS content o f supernatant
(b) Double reciprocal p lo t o f ANS binding data
Units o f ANS-fluorescence (F) are a rb itra ry .
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in tensity  is proportional to  the amount of protein but is increased in the 
presence o f biguanides (Schafer and Bojanowski, 1972). Increased prote in 
binding is measured in d irec tly  as a decreased fluorescence in the 
supernatant o f the prote in suspension a fte r centrifugation. Incubation of 
ANS and phenform in ( 0 - 5  mM) w ith  ra t and guinea-pig live r 
sub-m itochondria l partic les (equivalent amounts o f protein), resulted in 
essentially identica l decreases in ANS-fluorescence (Figure 2.4(a)). 
Linear regression analysis o f the reciprocal p lo t of protein-bound ANS 
(decrease in fluorescence) versus phenform in (Figure 2.4(b)) yielded an 
a ff in ity  constant, o f 0.31 m M "^.
Although v ir tu a lly  identica l binding o f phenform in to
sub-m itochondria l partic les from  guinea-pig and ra t live r m ight be 
expected to e ffe c t s im ilar changes in the function o f membrane proteins, 
determ ination o f NADH-ubiquinone oxidoreductase a c tiv ity  in the two 
preparations pre-incubated w ith  phenform in gave dissim ilar results.
A high concentration o f phenform in (10 mM) pre-incubated w ith  
ra t live r sub-m itochondrial partic les (Table 2.2) caused a s ign ifican t 
(p < 0.001) decrease (24%) in the a c tiv ity  o f NADH-ubiquinone 
oxidoreductase from  0.83 to 0.63 nmol O2 reduced/m in/m g prote in; the 
same concentration o f 4-hydroxyphenform in and a lower concentration 
o f phenform in (1 mM) had no s ign ifican t e ffe c t on the enzyme, as 
measured using the O g-electrode. M etform in (10 mM) caused a less 
s ign ifican t decrease (p < 0.05) in enzyme a c tiv ity  from  0.71 to
0.63 nmol Og reduced/m in/m g protein (11%). In contrast, 10 mM
phenform in pre-incubated w ith  guinea-pig live r sub-m itochondria l 
partic les (Table 2.3) caused a s ign ifican t (p < 0.001) increase (88%) in the 
a c tiv ity  o f the enzyme from  0.67 to 1.26 nmol 
reduced/m in/m g prote in; 1 mM phenform in caused a non-s ign ifican t 
increase (16%) from  0.62 to 0.72 nmol Og reduced/m in/m g prote in .
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4-Hydroxyphenform in (10 mM) and m etform in (10 mM) had no s ign ifican t 
e ffe c t on enzyme a c tiv ity .
Succinate-ubiquinone oxidoreductase a c tiv ity  in ra t live r
sub-m itochondria l partic les (Table 2.4) was s ign ifican tly  decreased
(p < 0.001) by 10 mM phenform in and 10 mM 4-hydroxyphenform in: both 
compounds reduced a c tiv ity  by approxim ately 37%. M etfo rm in  (10 mM) 
caused a s ign ifican t (p < 0.001) decrease (25%) in enzyme a c t iv ity  from  
1.61 to 1.21 nmol O2 reduced/m in/m g prote in; 1 mM m etfo rm in  caused a 
less s ign ifican t decrease (p < 0.005) from  1.61 to 1.44 nmol O2
reduced/m in/m g protein (11%). Phenform in (1 mM) and 1 mM 
4-hydroxyphenform in had no s ign ifican t e ffe c t on succinate-ubiquinone 
oxidoreductase a c tiv ity , although the rate o f respiration in the presence 
o f 1 mM phenform in was s ligh tly  increased (10.5%) from  1.61 to 
1.78 nmol O2 reduced/m in/m g prote in.
In contrast w ith  the ra t preparation, no succinate-ubiquinone
oxidoreductase a c tiv ity  could be demonstrated in the preparation o f 
guinea-pig live r sub-m itochondria l partic les.
2.3.3. E ffe c t o f Phenform in on Isolated, Coupled Rat Hepatic M itochondria
Succinate-supported state III respiration was reduced (p < 0.05) in
the absence of Ca^^ in the incubation medium (Figure 2.5). C ontro l
values, in the absence of phenform in, were 31.60 nmol O2
reduced/m in/m g protein ( C a ^^—20 nM) and 22.22 nmol O2
reduced/m in/m g ( Ca^^ < 0.001 nM). Under these conditions respiration
was progressively inhib ited by phenform in: a c tiv ity  was v ir tu a lly
abolished a t drug concentrations of 3 mM. The degree o f inh ib ition
would appear to be essentially s im ila r in the presence or absence of 
2+Ca ; FC^q values were identica l (0.45 mM).
- 39 -
Figure 2.5 EFFECT OF PHENFORMIN ON SUCCINATE-SUPPORTED STATE I I I  RESPIRATION
IN ISOLATED RAT HEPATIC MITOCHONDRIA
28-
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CONCENTRATION OF PHENFORMIN (mM)
Mitochondria (5 - 10 mg p ro te in ) were pre-incubated w ith phenformin HCl 
( 0 - 3  mM). State I I I  re sp ira tio n  w ith 5 mM succinate was determined 
in the presence (o, approximately 20 nM) or absence (®, < 0.001 nM) o f 
Ca2+. Values are means ± S.E.M. fo r  between 8 and 12 determ inations.
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Figure 2.6 EFFECT OF PHENFORMIN ON 2-OXOGLUTARATE-SUPPORTED STATE I I I  
RESPIRATION IN ISOLATED RAT HEPATIC MITOCHONDRIA
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Mitochondria (5 - 10 mg p ro te in ) were pre-incubated w ith phenformin HCl 
(0-3 mM). State I I I  re sp ira tio n  w ith 5 mM 2-oxoglutarate was determined 
in  the presence (o, approximately 20 nM) or absence (o, < 0.001 nM) o f 
C a 2 + .  Values are means ± S.E.M. fo r  between 8  and 10 determ inations.
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2-O xoglutarate-supported state III respiration was s im ila rly  
reduced (p < 0.02) in the absence of Ca^"^ (Figure 2.6). Contro l values in 
the absence of phenform in were 7.90 nmol O2 reduced/m in/m g protein 
( Ca^"^ c:^20 nM) and 5.56 nmol O2 reduced/m in/m g prote in 
( Ca^^ < 0.001 nM). Progressive inh ib ition w ith  phenform in, in the 
presence of Ca^"*", followed a s im ila r pattern to inh ib ition of 
succinate -supported respiration ( + Ca^^), w ith  to ta l inh ib ition at 
approxim ately 3 mM phenform in (EC^g> 0.5 mM): inh ib ition  in the 
absence of Ca^"^ would appear to be markedly d iffe re n t w ith  only 49% of 
contro l at 3 mM phenform in. A near-hyperbolic p lo t was seen w ith  
succinate and oxoglutarate oxidation in the presence o f Ca^"^; a fte r 
depletion w ith  EGTA the rate o f oxoglutarate oxidation was linear w ith  
respect to phenform in concentration, suggesting a d iffe re n t mechanism 
o f inh ib ition .
2.3.4 E ffe c t o f Presence of Phenform in during M itochondria l Isolation on 
M itochondria l Ca ~^^  Content
Incubation o f ANS and phenform in ( 0 - 5  mM) w ith  ra t, guinea-pig 
and hamster m itochondria (equivalent amounts o f protein), resulted in an 
essentially identicaPdecrease in ANS-fluorescence (Figure 2.7(a)). The 
a ff in ity  constant (K^^^) o f 0.89 mM~^, was determ ined from  the 
double-reciprocal p lo t o f protein-bound ANS (decrease in fluorescence) 
versus phenform in (Figure 2.7(b)).
Exposure o f contro l guinea-pig live r m itochondria to  increasing 
concentrations o f phenform in (0 -  10 mM) during the iso lation procedure 
resulted in a concentration-dependent decrease in m itochondria l Ca^^ 
content apparently reaching a plateau (35%) between 5 - 1 0  mM 
phenform in (Figure 2.8). In a com parative study between ra t, guinea-pig 
and hamster live r m itochondria exposed to 10 mM phenform in during
- 42 -
Figure 2.7 INFLUENCE OF PHENFORMIN ON BINDING OF ANS TO RAT, 
GUINEA-PIG AND HAMSTER LIVER MITOCHONDRIA
o o
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Control l iv e r  mitochondria were iso la ted from Wistar 
alb ino ra t (a ), guinea-pig ( a ) ,  and hamster (o ). 
M itochondrial fra c tio n s  were incubated w ith 0 - 5 mM 
phenformin HCl and 30 pM ANS.
(a) Decrease in ANS content o f m itochondrial supernatant
(b) Double reciproca l p lo t o f ANS binding data.
Units o f ANS-fluorescence (F ), are a rb itra ry .
43 -
Figure 2.8 VARIATION IN Ca CONTENT OF GUINEA-PIG LIVER MITOCHONDRIA 
WITH d ifferen t CONCeNTR'ATIOIS' Of PHENFORMIN IN THE ISOLATION
MEDIUM “
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Livers were removed from normal guinea-pigs. A portion  o f each 
l iv e r  was used to iso la te  contro l mitochondria in  Tris/sucrose 
medium; the remainder were iso la ted in Tris/sucrose medium^^ 
containing (0.1 - 10 mM) phenformin HCl. M itochondrial Ca 
was determined in each fra c t io n : resu lts  are expressed as 
percentage o f the corresponding contro l (20.8 - 24.1 nmol 
Ca2+/mg p ro te in ); duplicates gave ide n tica l values.
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OXOGLUTARATE
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Figure 2.9 GUINEA-RIG LIVER MITOCHONDRIA ISOLATED WITH 10 mNI RHENFORMIN. 
ABSENCE OF RESRIRATORY CONTROL WITH OXOGLUTARATE.
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Figure 2.10 GUINEA-PIG LIVER MITOCHONDRIA ISOLATED WITH 10 mM PHENFORMIN, 
ABSENCE OF RESPIRATORY CONTROL WITH SUCCINATE.
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isolation procedures (Table 2.5), ra t live r m itochondria appeared the 
most sensitive: mean Ca^"*" content of treated m itochondria was 54% of 
controls (p < 0.001). Phenform in caused a decrease in Ca^'*’ content o f 
guinea-pig (27%) and hamster (36%) live r m itochondria, although these 
results were not s ign ifican tly  d iffe re n t from  contro l values. Under these 
conditions, addition o f phenform in (10 mM) to the isolation medium 
abolished resp ira tory contro l in guinea-pig live r m itochondria u tilis ing  
2-oxoglutarate (Figure 2.9) or succinate (Figure 2.10).
2.4 DISCUSSION
Although phenform in abolished the hyperglycaemic e ffe c t o f an 
intravenous infusion o f lacta te  in fed rats (Assan et a l., 1978), few  
studies have been reported o f the e ffe c t o f adm in istra tion o f 
gluconeogenic compounds on the hypoglycaemic and hyperlactataem ic 
actions o f phenform in in v ivo . Evans et al., (1983) demonstrated 
pronounced hypoglycaemia and raised blood lacta te  concentrations in 
starved rats treated w ith  phenform in: blood glucose concentrations 
continued to fa ll and hyperlactataem ia became more pronounced over a 
period o f 3 h. Upon adm in istra tion o f various gluconeogenic compounds, 
1 h a fte r pre trea tm ent w ith  phenform in, succinate and malate prevented 
the development o f marked hypoglycaemia; lacta te , 2-oxog lu tara te  and 
c itra te  had less e ffe c t. S im ila rly , the increase in blood lac ta te  
concentrations above in it ia l levels, in animals receiving oxoglutarate, 
lac ta te  and c itra te , were s im ila r to or greater than those found in 
phenform in-pretreated animals receiving only saline. Succinate, and to 
a lesser extent m alate, prevented any s ign ifican t increase in 
phenform in-induced hyperlactataem ia beyond tha t established a t the 
tim e o f adm in istration o f the gluconeogenic load. Concom itant
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adm in istra tion o f succinate and phenformin s ign ifican tly  decreased both 
the hypoglycaemic and hyperlactataem ic e ffec ts  of the biguanide.
Oral adm in istra tion o f disodium succinate s ign ifican tly  reversed 
the pronounced c lin ica l signs o f la c tic  acidosis and decreased the 
incidence of m o rta lity  in male and female mice pretreated w ith  
phenform in (Table 2.1). These results suggest tha t most substrates which 
are metabolised in the ir f irs t  nucleotide-requ iring reaction by 
NAD'^-dependent enzymes (c itra te , oxoglutarate, lacta te) are unable to 
prevent e ither the hypoglycaemic or hyperlactataem ic e ffe c t o f 
phenform in; succinate, a substrate metabolised by an FAD-dependent 
dehydrogenase, would appear able to prevent or even reverse these 
e ffec ts .
A possible mode o f action fo r phenform in may be in the prevention 
o f gluconeogenesis from  c itra te , oxoglutarate and lac ta te  by inh ib ition  
o f m itochondria l NADH-ubiquinone oxidoreductase (Complex I, 
Figure 2.11). NADH-ubiquinone oxidoreductase is a discrete functiona l 
component o f the inner m itochondria l membrane which mediates the 
transfer o f electrons from  the soluble dehydrogenases o f the c it r ic  acid 
cycle, via the N AD H /N AD ^ couple, to the membrane-bound respiratory 
chain. NADH is oxidised on the m a trix  face o f the membrane by an 
FM N-contain ing component, NADH-dehydrogenase. Impaired function 
o f the complex leads to an increase in the m itochondria l N A D H /N AD ^ 
ra tio , inh ib ition of oxidative phosphorylation and s tim u la tion  o f 
anaerobic glycolysis.
In addition to Complex I, three other redox pathways feed 
electrons in to the respiratory chain a t ubiquinone (UQ) (Figure 2.11): 
Complex II, which transfers electrons from  succinate, containing 
succinate dehydrogenase and covalently bound FAD; 
e lec tron -transfe rring  prote in, supplying electrons from  the
- 49 -
SUCCINATE
ADP + Pi
SITE I
ATP
E lectron -transfe rring
flavopro te in;
a-glycerophosphate
(III)
NADH + H
FMNHo + 5 Fe/S
FADHo + 2 Fe/5
(
ADP + Pi 
'ATP
SITEH
(IV) 2 Cu + a/a-
I
ADP -h Pi 
ATP
i  O,
S IT E ffl
Figure 2.11 RESPIRATORY CHAIN AND SITES OF OXIDATIVE PHOSPHORYLATION
Structura l Complexes: (I) NADH-UQ oxidoreductase; (II) Succinate-UQ 
oxidoreductase; (III) UQH2-cytochrom e c oxidoreductase; (IV) Cytochrom e c 
oxidase. Complexes I, III and IV are H -translocating . (UQ, Ubiquinone).
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flavop ro te in -linked  step o f fa tty  acid 6-oxidation; a-glycerophosphate 
dehydrogenase, catalysing the ex tra -m itochondria l oxidation o f 
a-glycerophosphate to dihydroxyacetone phosphate. The f irs t  two are 
located on the m atrix  face (M -face) o f the membrane while
a-glycerophosphatase is bound to the outer face (C -face). Transference 
o f reducing equivalents derived from  these substrates, d ire c tly  to UQ 
would e ffe c tiv e ly  bypass the postulated inh ib ition  o f NADH-ubiquinone 
oxidoreductase by phenform in. I t  is possible tha t compounds other than 
succinate may reverse the m etabolic e ffec ts  of phenform in via th is 
mechanism and may explain the reported e ffec ts  o f g lycery l tr ip a lm ita te  
in this respect (Muntoni et al., 1978). The strength o f th is argument is 
lessened by the evidence tha t malate may produce some a llev ia tion  o f 
both the hypoglycaemic and hyperlactataem ic e ffec ts  o f phenform in, in 
contrast to other NAD"^-dependent substrates. Malate may have given 
rise to glucose through the action o f ex tra -m itochondria l m alate 
dehydrogenase and phosphoenolpyruvate carboxykinase: i t  is more 
d if f ic u lt  to envisage how the hyperlactataem ic e ffe c t o f the drug was 
am eliorated w ithout m itochondria l energy production. This finding may 
suggest tha t the action o f phenform in results in the inh ib ition  of 
m itochondria l NAD^-dependent dehydrogenases other than m alate 
dehydrogenase, rather than inh ib ition  o f NADH-ubiquinone 
oxidoreductase.
Investigations o f various energy-linked or resp ira tion -linked  
functions have suggested tha t the m etabolic e ffec ts  o f biguanides could 
be a ttribu ted  to the inh ib ition o f energy conservation; the m olecular 
basis of this action remains uncertain. O xidative phosphorylation was 
shown to be inhib ited by guanidine (Chance and Hollunger, 1963) and also 
by a lky l guanidines and biguanides (Pressman, 1963; Chappell, 1963). The 
phenomenon o f ADP-induced resp ira tory contro l is no longer observed;
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inh ib ition  o f respiration can be released by uncouplers. Inh ib ition by 
phenform in has been reported at a ll three m itochondria l phosphorylation 
sites (Figure 2.11). Early work by Steiner and W illiams (1958), using 
whole homogenates and coupled m itochondria l preparations, suggested 
tha t the prim ary point o f inh ib ition  was a t cytochrome oxidase (Site III); 
no inh ib ition  was seen at Site I. La ter reports have ascribed greatest 
localised inh ib ition  to Site II: Pressman (1963) presented evidence to
suggest tha t phenform in se lective ly acts at th is part o f the respiratory 
chain; Wick et a l., (1958) suggested the point o f inh ib ition as being 
'somewhere between succinic dehydrogenase and cytochrome c' 
( inh ib ition a t Site I was not investigated). Haas (1964) could demonstrate 
no inh ib ition  o f Site I in phosphorylating digitonin fragments o f 
bee f-heart m itochondria. A more recent report by Ogata et W., (1974)
has shown tha t guinea-pig live r m itochondria are more sensitive to
inh ib ition  o f oxidative phosphorylation by phenformin than are ra t liv e r 
m itochondria. Studies in coupled guinea-pig m itochondria indicated tha t 
phenform in at low concentrations (0.1 mM) inhib ited a t Site I; a t higher 
concentrations (0.5 mM) Site II was also inh ib ited.
I t  is d if f ic u lt  to draw conclusions from  such diverse reports as to 
the nature o f any 's ite -s p e c ific ity ' demonstrated by the action o f 
phenform in on the respiratory chain. According to the chem iosmotic 
theory, the translocation o f protons across the inner m itochondria l 
membrane is in tim a te ly  linked to electron transport through the
respiratory chain, creating an e lectrochem ical gradient su ffic ie n t to 
drive the phosphorylation o f ADP by the functiona lly  d is tin c t 
ATP-synthetase complex; the 'phosphorylation sites' o f pre-osm otic
theory are roughly analogous to the proton - translocating component^of 
the respiratory chain (Figure 2.11). The uptake o f protons (or other ions) 
is determined by the membrane surface potentia l which may be
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modulated by binding o f charged species such as the guanidinium cation 
m oiety o f a lky l biguanides (reviewed by Schafer, 1980). Generation o f a 
positive sh ift in membrane surface potentia l, due to hydrophobic 
in te rac tion  o f biguanides w ith  membrane components, is associated w ith  
concom itant inh ib ition o f oxidative phosphorylation (Schafer and 
Rowohl-Quisthoudt, 1975). A ll biguanides cause a
concentration-dependent inh ib ition  o f proton movement across the inner 
m itochondria l membrane in both d irections, i.e. aerobic extrusion o f 
protons fo llow ing an oxygen-pulse; u tilisa tion  o f protons in oxidative 
phosphorylation (Schafer and Rowohl-Quisthoudt, 1975; Schafer et 
^ . ,  1974). The release o f inh ib ition  by uncouplers may easily be 
in terpre ted as the sho rt-c ircu itin g  o f proton movements by proton 
conductors. Although no evidence o f 's ite -sp e c ific ity ' was detected in 
these experiments (Schafer, 1980) i t  is possible tha t individual guanidines 
(and biguanides) may exert superimposed inhib itions on specific e lectron 
transfer complexes w ith in  the respiratory chain (M itche ll, 1966). The 
use o f sub-m itochondria l partic les, w ith  inverted membrane orien ta tion  
re la tive  to m itochodria, enables the investigation o f any d irec t e ffe c t o f 
phenform in on the pelos o f NADH and succinate oxidation. The enzymes, 
NADH dehydrogenase and succinate dehydrogenase, are free ly  accessible 
to th e ir respective substrates; Bohnensack e t (1982) cla im  tha t the 
ra te -co n tro llin g  step in oxidative phosphorylation is the supply o f 
hydrogen ions to the respiratory chain.
The binding o f phenform in to sub-m itochondrial partic les prepared 
from  ra t and guinea-pig live r would appear to be s im ila r 
(Kass = 0.31 mM ^), (Figure 2.4). This finding is consistent w ith  the view 
tha t biguanides bind non-specifica lly  to membrane phospholipids 
(Schafer, 1974a). Although inh ib ition  o f N AD H -oxidation in uncoupled 
ra t live r sub-m itochondria l partic les by n-hep ty l biguanide has been
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c ited by Schafer (1980), a s im ila r e ffe c t (Table 2.2) was observed w ith  
phenform in only at very high concentrations (10 mM). M etform in had 
only negligible inh ib ito ry  e ffe c t a t the same concentration; 
4-hydroxyphenform in had no e ffe c t on respiration. n -H ep ty l biguanide 
was reported by Schafer as having no e ffe c t on succinate oxidation: 
phenform in, m etfo rm in  and, surprisingly, 4-hydroxyphenform in caused 
inh ib ition  o f respiration (Table 2.4) but only at high concentrations 
(although some evidence o f inh ib ition  w ith  1 mM m etform in was noted). 
Phenform in (10 mM) appeared to stim ulate (88%) N AD H -oxidation by 
guinea-pig live r sub-m itochondria l partic les (Table 2.3), but the e ffe c t 
was not s ign ifican t a t a lower concentration (1 mM); 10 mM m etform in 
and 4-hydroxyphenform in had no e ffe c t on respiration.
I t  would appear tha t although there are clear d ifferences in the 
e ffe c t o f biguanides on NADH and succinate oxidation in 
sub-m itochondria l partic les, they are apparent only at high 
concentrations. It  seems unlike ly tha t accumulation o f biguanides on the 
inside o f the m itochondrion would have any d irec t e ffe c t upon NADH and 
succinate dehydrogenase in v ivo; there is no evidence to suggest any 
pa rticu la r sens itiv ity  o f the guinea-pig in this respect.
McCormack and Denton (1980) found tha t Ca^^ had no e ffe c t on 
succinate oxidation in uncoupled m itochondria from  brown adipose tissue 
o f cold-adapted rats. In contrast, Ca^^ increased the rate o f oxidation 
in coupled ra t live r m itochondria (Figure 2.5). The increase may 
represent a degree o f uncoupling due to resp ira tion-linked accum ulation 
o f Ca^^ a t the expense o f ATP synthesis (Lehninger, 1974). Ca^^ also 
increased the rate o f oxidation o f 2-oxog lutarate (Figure 2.6). S im ilar 
e ffec ts  o f Ca^"*" on 2-oxoglutarate dehydrogenase a c tiv ity  have been 
reported in m itochondria l extracts (McCormack and Denton, 1980) and in 
coupled and uncoupled m itochondria (Denton et a l., 1980; McCormack
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and Denton, 1980); increasing Ca^^ led to a greatly decreased K ^ ,  w ith
li t t le  or no e ffe c t on V . Ca^'*’ may redistribute across the innermax
membrane during procedures associated w ith  tissue homogenisation and
subsequent isolation o f m itochondria (discussed in 3.1); measurement o f
m itochondria l Ca^^ content a fte r inclusion o f phenform in in the
homogenisation medium was considered to be more representative o f the
e ffe c t o f the drug in v ivo . Guinea-pig live r m itochondria isolated in the
presence o f phenform in (10 mM) showed no respiratory contro l w ith
added ADP when u tilis ing  e ither 2-oxoglutarate or succinate (Figure 2.9;
Figure 2.10). Phenform in caused a decrease in Ca^'*’ content in live r
m itochondria from  ra t, guinea-pig and hamster isolated under s im ila r
conditions (Table 2.5); the decrease in Ca^^ was shown to be
concentration dependent in guinea-pig live r m itochondria (Figure 2.8).
Although binding a ff in ity  fo r phenform in was sim ilar in m itochondria
from  the three species investigated (Figure 2.7), ra t liv e r m itochondria
were s ligh tly  more sensitive (50% decrease) to the biguanide w ith  
2+respect to Ca depletion (Table 2.5). These results suggest tha t
phenform in may modulate the transport of Ca^^ across the inner
m itochondria l membrane in a s im ila r fashion and in addition to the
modulation o f proton movements previously discussed; reduced
m itochondria l Ca^^ fo llow ing incubation o f isolated ra t liv e r
m itochondria w ith  phenform in m ight be expected to potentia te  the
24-e ffe c t o f altered extra -m itochondria l Ca on in tra -m itoch ond ria l 
Ca^^-sensitive enzymes as reported by Denton e t a l. (1980).
Phenform in caused a concentration-dependent inh ib ition  o f both 
succinate and oxoglutarate oxidation in coupled ra t live r m itochondria  
(Figure 2.12; data derived from  Figures 2.5, 2.6); both reactions were
inhib ited to a s im ilar extent in the presence o f Ca^^ (^^20 nM). In
contrast, Ogata et ^ . ,  (1974) showed tha t coupled guinea-pig liv e r
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Figure 2.12 EFFECT OF PHENFORMIN ON 2-OXOGLUTARATE AND SUCCINATE SUPPORTED 
STATE I I I  RESPIRATION IN ISOLATED RAT HEPATIC MITOCHONDRIA
100
I—
CO
20  •
1 . 0 2 . 0 3.0
CONCENTRATION OF PHENFORMIN (mM)
Succinate dehydrogenase; [Ca2+] < 0.001 nM 
Succinate dehydrogenase; [Ca2+] s 20 nM 
2-oxoglutarate dehydrogenase; [Ca^*] < 0.001 nM
2-oxoglutarate dehydrogenase; [Ca^+Î = 20 nM
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m itochondria oxidising malate (plus glutamate) were more sensitive to 
inh ib ition  by phenform in than those oxidising succinate. Depletion o f 
ex tra -m itochondria l Ca^"*" w ith  EGTA had no e ffe c t on the inh ib ition  o f 
succinate oxidation by phenform in (Figure 2.5, Figure 2.12). In the 
absence o f extra -m itochondria l Ca^^ the oxidation o f 2-oxog lu tara te  
was less susceptible to inh ib ition  by phenform in (Figure 2.6, Figure 2.12); 
the drug would appear to e ffe c t a d iffe re n t mechanism o f inh ib ition , as 
evidenced by the d ifference in the pattern  o f inh ib ition (i.e. linear w ith  
respect to drug concentration) over the range 0 - 3  mM phenform in. 
Decrease in the ra te  o f succinate oxidation, and o f oxoglutarate 
oxidation (in the presence o f Ca^^) may be explained by inh ib ition  o f 
oxidative phosphorylation; the lim ite d  inh ib ition o f 2-oxog lutarate 
respiration in the absence of Ca^^ is less easily explained. Two d iffe re n t 
mechanisms may be acting simultaneously: decreased Ca^'^-stim ula ted 
oxidation o f 2-oxoglutarate and inh ib ition  o f oxidative phosphorylation. 
In conditions o f low extra -m itochondria l Ca^"*", C a^^-s tim u la ted  
oxidation of oxoglutarate is a t a m inimum and hence the enzyme is 
rendered insensitive to any Ca^^-dep letion e ffe c t o f phenform in; 
inh ib ition  o f th is lowered respiration ra te  may be explained by the action 
o f phenform in on oxidative phosphorylation.
The indications tha t phenform in may exert an e ffe c t on 
in tra -m itochondria l enzymes via depletion of m itochondria l Ca^'*’ in 
v itro  would seem to warrant investigation o f any s im ila r e ffe c ts  in vivo.
CHAPTER THREE
EFFECT OF PHENFORMIN ON INTRACELLULAR Ca^^ DISTRIBUTION
IN THE LIVER
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3.1 INTRODUCTION
The chem iosmotic hypothesis (M itche ll, 1966) states tha t under 
energised conditions (i.e. in the presence o f reducible substrate) 
m itochondria w ill pump out protons, creating a proton electrochem ical 
potentia l ( Ap^+) across the energy-transducing membrane. Proton 
electrochem ical potentia l is a thermodynamic measure o f the extent to 
which the proton gradient across the membrane is removed from  
equilibrium  and has both a concentration ( ApH) and an e lec tr ica l ( A Y  )  
component:
A mj_^ + = ay - k . a pH
Electron transfer through the membrane and ATP synthesis on the 
M -face are linked via independent, reversible proton pumps 
(Figure 3.1); AUj_^ + generated by resp ira tion-driven pro ton-translocation 
is su ffic ien t to drive an ATP-hydrolysing proton pump (ATP synthetase) 
in the d irection o f ATP synthesis. The membrane potentia l ( AY  ) is a 
measure o f the extent to which the inside o f the m itochondrion is 
negatively charged w ith  respect to the external medium. This potentia l 
is su ffic ien t to drive the e lectrophoretic  uptake o f Ca^^ from  the 
cytoplasm (N icholls and Crompton, 1980) and provides a simple 
explanation fo r the enormous capacity o f m itochondria to accumulate 
C a ^ \
The d istribu tion o f a d ivalent, permeable ion across a membrane is 
determined by the transmembrane e lec tr ica l po ten tia l (e.g. fo r Ca^'^, 
A iJpo2+)î
'  2+
^UQg2+ = 2 .AY _ 2 .3 —  In ^ ^ ^  ^INSIDE
F CCa^ "^ ]-^OUTSIDE
T is absolute tem perature; R and F are constants.
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C-FACE M-FACE
SH2+ i 0/
ADP + Pi
ATP
Figure 3 .1 . PROTON ELECTRO-CHEMICAL COUPLING IN THE INNER 
MITOCHONDRIAL MEMBRANE; GENERATION OF AY
AND ApH.
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A t equilibrium  AMQg2+ = 0; re-arrangem ent gives the Nernst equation:
= 2.3 —   ^INSIDE
f Ca^^] OUTSIDE
From measured values o f membrane potentia l o f approxim ately 180 mV, 
a Ca^^ concentration gradient o f 10^ may be predicted across the inner 
m itochondria l membrane at equ ilibrium . The presence o f phosphate 
w ith in  the m atrix  probably prevents the free m atrix  Ca^^ concentration 
from  rising much above 1 mM, im plying tha t the equilibrium  cytosolic
concentration should be as low as 10" M. In contrast, most estimates of
2+ ' 7cytosolic free Ca are in the range 10" -  10" M. The existence o f a
single uniport ca rrie r in the m itochondria l membrane would not only
resu lt in the prec ip ita tion  o f Ca^(P0^)2 w ith in  the m itochondria but
would also enable the d is tribu tion  o f Ca^^ between cytosol and m atrix  to
be regulated only by a lte ra tion  o f the membrane potentia l, which would
in turn disturb ATP synthesis and m etabolite  d is tribu tion . This apparent
paradox was solved by the discovery o f independently operating e fflu x
pathways in live r (Puskin e t a l., 1976) and heart m itochondria (Crompton
eit a l., 1976).
In heart m itochondria, the e fflu x  pathway exchanges Ca^^ fo r 
Na in the live r, Ca^^ is u ltim a te ly  exchanged fo r protons. O vera ll, a 
slow continuous cycling o f Ca^^ occurs across the membrane at the 
expense o f a slight u tilisa tion  o f a P|_|+. These independently operating 
uptake and e fflu x  pathways allow  Ca^^ d is tribu tion  to be regulated 
w ithout disturbing membrane po ten tia l (N icholls, 1981); a s ligh t change 
in the rate o f e ither pathway can induce a large percentage change in 
the net flu x . Isolated m itochondria w ill bu ffe r the concentration o f 
ex tra -m itochondria l Ca^^ ( [C a ^ ^ ]^ )  (Figure 3.2), but only i f  the m a trix  
contains su fic ien t Ca^^ to saturate the e fflu x  pathway. I f  [ Ca^^ is 
maintained consistently below the se t-po in t fo r m itochondria l bu ffe ring .
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Figure 3.2 The regula tion o f extra-m itochondrial Ca  ^ concentrations.
The e ff lu x  pathway works at a constant rate (3 nmol/min/mg 
in th is  example). The uptake pathway is dependent on the 
extra-m itochondria l Ca2+ concentration. Net uptake occurs 
i f  the concentration of free external Ca^+ is above the 
se t-p o in t, net release i f  the concentration is  below the 
se t-po in t. The se t-p o in t, i .e .  when uptake and e ff lu x  
balance, can be a lte red  by a c tiva tin g  and in h ib it in g  
e ith e r pathway, e.g. in h ib it io n  o f the uptake pathway s h if ts  
the se t-po in t to a higher value.
From N icholIs (1981)
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e.g. by the use o f chelators or Ca^'*’ transport across non-m itochondria i 
membranes, then m itochondria l Ca^^ w ill become depleted. The a c t iv ity  
o f the e fflu x  pathway w ill decrease and eventually balance the low
a c tiv ity  o f the uptake pathway. This balance w ill occur when the free 
Ca^'*' concentration in the m atrix  (ÇCa^'*’ ] ^ )  decreases below the 
fo r the e fflu x  pathway. Under these conditions, i f  [C a^ '"'] ^ is 
maintained at a constant value, m itochondria w ill regulate [  Ca^"^] ^  
ra ther than [Ca^"^].^. I t  has been proposed tha t changes in m a trix  Ca^^ 
concentration in vivo could theo re tica lly  influence m itochondria l 
metabolism in response to ex tra -m itochondria l signals (Denton e t 
al., 1980). An explanation o f the action o f biguanides on gluconeogenesis 
which involves im pairm ent o f hormonal regulation through altered 
in trace llu la r calcium d istribu tion  has been suggested (D avidoff, 1974; 
D avido ff et al., 1978; D av ido ff and Haas, 1979).
Experiments were designed to measure liv e r m itochondria l calcium  
content fo llow ing adm in istra tion o f biguanides in v ivo . Sub-ce llu lar 
frac tiona tion  may result in the re -d is tribu tion  o f Ca^^ between 
m itochondria and the ex tra -m itochondria l environment, and hence 
abolish any e ffects  established in v ivo . In addition, Ca^"^ bound to  
m itochondria l sites external to the m atrix  may represent a po ten tia l 
source o f in terference in the measurement o f in tra -m itochond ria l Ca^^ 
(Bygrave, 1977). M inim isation o f post-homogenisation a rte fac ts  was 
achieved by the use o f a specific  Ca^^ chelator and the selective 
inh ib ition  o f m itochondria l Ca^^ transport (see section 3.2.3). Since a 
collapse in membrane potentia l may result in red is tribu tion  o f 
m itochondria l Ca^"^ (N icholls and Brand, 1980), m itochondria were 
energised w ith  succinate in some experiments. Determ inations o f liv e r 
m itochondria l Ca^^ fo llow ing phenform in in v ivo , were made in fed and 
starved guinea-pigs, rats and hamster. L ive r m itochondria l Ca^+ values
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in the guinea-pig were corre lated w ith  blood lacta te  and glucose 
concentrations in v ivo . The e ffe c t o f phenform in on in trace llu la r Ca^^ 
homeostasis was investigated in isolated ra t hepatocytes using the 
fluorescent Ca^'*' ind ica tor, Quin 2 (Tsien, 1980).
3.2 MATERIALS AND METHODS
3.2.1 Chemicals
M ersalyl acid (MERS) and collagenase (Type IV) were purchased 
from  Sigma (London) Chemical Co. L td ., Poole, Dorset, England. 
Ruthenium Red (RR) was used as the unpurified preparation supplied by 
Sigma; where indicated, concentrations are o f actual dye content (45%). 
Sodium pentobarbitone solution (Sagatal) was supplied by May and Baker 
L td ., Dagenham, Essex, England. Reagents fo r electron microscopy were 
obtained from  EMscope L td ., Ashford, Kent, England; sodium cacodylate 
was supplied by Fisons S c ien tific  Apparatus, Loughborough, 
Leicestershire, England. Quin 2/AM  was purchased from  Lancaster 
Synthesis L td ., Morecombe, Lancashire, England. Cannulas (Abocath-T ; 
18 g X 22 mm, 22 g x 32 mm) were supplied by Abbott Laboratories L td ., 
Queensborough, Herts., England.
A ll other reagents were obtained from  the sources specified in
2.2.1.
3.2.2 Animals and Adm in istra tion  o f Compounds
Sources and weights o f animals were as outlined in 2.2.2. Where 
indicated, starved animals were deprived of food fo r about 24 h; w ater 
was allowed ad lib itu m .
Phenform in HCl, 4-hydroxyphenform in HC l and m etfo rm in  H C l 
were dissolved in isotonic saline (0.9% w /v) such th a t the volume 
administered by in traperitoneal in jection was approxim ate ly 0.5 m l; 
contro l animals received equivalent volumes of saline.
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3.2.3 Isolation o f M itochondria
M itochondria were prepared essentially as described in 2.2.3. The 
isolation medium (0.25 M sucrose) contained 2 mM EGTA, 5 mM 
succinate, 10 pM mersalyl and 5 pM Ruthenium Red where indicated; a ll 
solutions were prepared in deionised w ater and adjusted to pH 7.6 before 
use.
Ethylene glycol bis(am inoethyl ether)N ,N ’-te tra a ce tic  acid (EGTA) 
is a pow erfu l chelator o f Ca^^ (Schmid and R e illy , 1957). Evidence 
suggests tha t EGTA is not accessible to the inner m itochondria l 
membrane m a trix  space: m itochondria l compartments accessible to
^^C -labe lled  sucrose and ^^C -labe lled  ethylenediamine te traace tic  acid 
(EOTA) are identica l (Harris and Van Dam, 1968); m itochondria l swelling 
does not occur in iso-osm otic solutions o f NH^-EGTA or N H ^-E D TA 
(Reed and Bygrave, 1974a). Although the use o f EGTA may induce 
m itochondria l Ca^^ e fflu x , i t  has been used as a quenching agent to 
in h ib it Ca^^ transport and remove externally-bound m itochondria l C a^* 
(Reed and Bygrave, 1974b).
Ruthenium Red, a complex ruthenium  salt w ith  the s tructu re  
[(N H ^)^R u -0 -R u (N H ^)^ -0 -R u (N H ^)^ ] C l^.4  H^O (F letcher et 
^ . ,  1961), is a powerfu l inh ib ito r o f respiration-dependent Ca^^ uptake 
by m itochondria (Moore, 1971). A t concentrations which e lim ina te  Ca^^ 
accum ulation the reagent does not in te rfe re  w ith  other energy-linked 
reactions (Vassington et a l., 1972); a concentration o f 3 pM is s u ffic ie n t 
to cause 99% inh ib ition  o f Ca^"^ transport (Reed and Bygrave, 1975). The 
crude complex contains a colourless im purity  which is uncharacterised, 
but is a potent inh ib ito r o f Ca^'*’ transport (Reed and Bygrave, 1974b). 
The e ffe c t o f Ruthenium Red on C a ^^-e fflu x  is unclear; evidence 
suggests tha t at least some Ca^^ e fflu x  in liv e r m itochondria is 
Ruthenium Red insensitive (reviewed by B rie rley and Jung, 1981):
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(a)
Ca'
Ca'
C-FACE M-FACE
à L
H'*' 1
1 r
/  RR
r-,2+
- V
PI ^
/
MERS
HI
MERS
A
(b)
Ca^ "^  (11 )
Figure 3.3 (a)
Inset (b)
A model fo r  m itochondrial transport o f Ca ^ and PI 
(adapted from Rugulo e t , 1981). C a 2 +  and PI 
enter on th e ir  own c a rrie rs  sens itive  to Ruthenium 
Red (RR) and mersalyl acid (MERS) respective ly . The 
p a ra lle l e ff lu x  o f Ca^ "^  and PI out o f mitochondria 
Is Insens itive  to RR and sens itive  to m ersalyl.
S im p lified  model o f Ca^^ transport In l iv e r  m itochondria. 
Respiration driven proton extrusion (1) generates a 
membrane po ten tia l which drives the uptake o f Ca2+
(11). In l iv e r  mitochondria Ca2+ e ff lu x  probably occurs 
In exchange fo r  protons (111) (N ich o lls , 1981).
S toichiom etries are not specified .
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addition o f Ruthenium Red to energised ra t live r m itochondria tha t had 
previously accumulated Ca^^ and phosphate, induced a para lle l e flux o f 
both ions (Siliprandi e t 1979). Rugalo et ^ . ,  (1981) have shown tha t 
both Ca^^ and phosphate movements in energised m itochondria are 
simultaneously and equally a ffected  by agents tha t spec ifica lly  m odify 
Ca "^** or phosphate transport, respectively (Figure 3.3). In pa rticu la r i t  
was shown tha t 10 pM mersalyl (sodium- -(3 -hydroxym ercuri-
2-m ethoxypropyl)carbam oyl-phenoxyacetate), a reversible inh ib ito r o f 
phosphate transport (Fonyo, 1981), also inhib its Ca^^ cycling w h ils t 
preserving membrane potentia l.
3.2.4 M arker-Enzym e A c tiv itie s
M itochondria were isolated, essentially as described in 2.2.3 and 
according to the scheme in Figure 3.4. Determ ination o f DMA, prote in 
and marker-enzym e ac tiv itie s  were made in the m itochondria l (P^) and 
residual frac tio n  (R.):
a c tiv ity  (R) = a c tiv ity  2(Pj^ + S2 + S?)
TOTAL a c tiv ity  = a c tiv ity  Z(R + P^)
Results are expressed as percentages o f to ta l a c tiv ity  (or amount) 
recovered.
(i) Estim ation o f DMA
DMA was estimated by an adaptation o f the method o f Burton 
(1956). Diphenylamine was reacted w ith  acid-hydrolysed DNA to give 
coloured products; the absorbance was measured at 600 nm against blank 
and compared w ith  standards.
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HOMOGENATE
1,000 g
S = supernatant 
P = pelle t
P^ (combined w ith  Sg + S^)
10,000 g
P2 (crude m itochondria l pe lle t)
Resuspended in fresh medium
10,000 g
/ \
P^ (washed m itochondria l pe lle t) 
Resuspended in fresh medium
Residual frac tion  (R) 
M itochondrial frac tion
Figure 3.4 FRACTIONATION SCHEME: ISOLATION
OF MITOCHONDRIA FOR CHARACTERISATION BY 
ENZYME MARKERS
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(ii)  Phosphodiesterase
A lka line phosphodiesterase was determined w ith  b is-p-n itrophenyl 
phosphate as substrate and was used as a convenient marker fo r plasma 
membrane fragments (Prospero and H inton, 1973).
( iii)  Succinate Dehydrogenase
Succinate dehydrogenase, measured as succinate 2-(p-indophenyl)-
3 -(p -n itrophenyl)-5-phenyl te trazo lian  (INT) reductase
(Pennington, 1961) was used as a convenient marker fo r m itochondria. 
The substrate (INT) is reduced to red, insoluble, formazan. The reaction 
was stopped by the addition o f a m ixture  o f TCA, e thyl acetate and 
ethanol to p rec ip ita te  prote in and ex trac t the product. Sodium succinate 
was replaced in blank assays by the specific inh ib ito r sodium malonate to 
account fo r non-specific  reduction o f INT.
(iv) Acid Phosphatase
Acid phosphatase was used as a lysosomal marker, using sodium
3-glycerophosphate as substrate. Tota l 3-glycerophosphatase a c t iv ity  
was measured in the presence o f detergent to disrupt the lysosomal 
membrane; 'fre e ’ enzyme a c tiv ity  (i.e. assayed in the absence o f 
detergent) was determined to give an indication o f contam ination w ith  
lysosomal fragments.
(v) Glucose-6-Phosphatase
Glucose-6-phosphatase was used as a convenient m arker fo r 
endoplasmic re ticu lum . Inorganic phosphate released by the enzyme was 
measured co lo rim e trica lly  by a procedure based upon the method of 
H inton e t a l., (1970).
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(vi) D eterm ination o f Inorganic Phosphate
Estim ation o f inorganic phosphate was adapted from  the method of 
Lowry and Copey (1946). Ammonium molybdate complexed w ith  
phosphate was reduced w ith  ascorbic acid to yie ld ’molybdenum blue’. 
The absorbance of the reduced complex was measured at 700 nm.
(v ii) Determ ination o f Protein
Prote in was determined by the method o f Lowry et (1951).
3.2.5 E lectron Microscopy
L ive r m itochodria were isolated, essentially as described in 2.2.4, 
and resuspended in 0.25 M sucrose, 3.4 mM T ris /H C l, pH 7.4 a t a 
concentration equivalent to 4 g orig inal tissue/m l.
A liquots (0.5 m l) were fixed in 4.5 m l glutaraldehyde (4% w /v) in 
0.1 M sodium cacodylate : HNO^ bu ffe r, pH 7.4 fo r 2 - 4 h a t 4°C . The 
m ateria l was washed in the cacodylate bu ffe r fo r 12 - 18 h at room 
tem perature. Samples were coun te r-fixed  in 2% (w /v) osmic acid 
buffered w ith  0.1 M sodium cacodylate ; HNO^, pH 7.4 fo r 2 h.
Fixed m ate ria l was dehydrated in progressively increasing 
concentrations of ethanol (25, 50, 75, 90 and 100% v/v), immersed in a 
1 : 1 m ixture o f propylene oxide : absolute alcohol, and fin a lly  in 
propylene oxide. Each solution was le f t  in contact w ith  the m ate ria l fo r 
10 min, replaced w ith  fresh medium and le f t  a fu rthe r 10 min. Samples 
were removed and covered w ith  a 1 : 1  m ixture  o f propylene 
oxide : Epon 812 resin fo r 20 min. Small amounts were transferred to 
re s in -fille d  capsules and the resin polymerised fo r 48 h a t 60°C.
Capsules were subsequently sectioned using a R eichert Orn U3 
U ltra -m ic ro to m e  and the samples examined under a Jeol lOOB e lectron 
microscope.
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3.2.6 Collection o f Blood Samples
Before co llection  o f blood samples, most animals were 
anaesthetised w ith  sodium pentobarbitone (60 m g/kg, i.p.); in some 
experiments animals were k illed  by cerv ica l dislocation and a te rm ina l 
blood sample taken. Samples were w ithdrawn from  the in fe rio r vena 
cava and 0.2 m l im m ediate ly expelled in to 0.4 m l 0.7 M ice -co ld  
perchloric acid: the de-protein ised samples were centrifuged
(1,500 r.p.m . fo r 5 min) and the supernatants used fo r the determ ination 
o f lac ta te . For the determ ination o f glucose, 0.5 m l whole blood was 
expelled in to heparinised blood tubes and centrifuged to  obtain plasma.
A ll animals were k illed  before recovery from  anaesthesia.
3.2.7 Determ ination o f Glucose and Lacta te
Lacta te  and glucose were determined on a Cobas Bio cen trifuga l 
analyser (Roche Products L td ., Welwyn Garden C ity , H ertfo rdsh ire , 
England) using Boehringer (Lacta te ; Cat. No. 124842), (Boehringer 
Corporation (London) L td ., Lewes, East Sussex, England) and Roche 
(Glucose; L is t No. 0711004) assay k its.
3.2.8 Isolation o f Hepatocytes
A du lt male W istar albino rats (University o f Surrey stra in ; 
approxim ately 250 g) were anaesthetised w ith  sodium pentobarbitone 
(60 mg/kg, i.p.). Each animal was placed in a supine position w ith  the 
ventra l side exposed, opened w ith  two deep la te ra l cuts and the viscera 
deflected to the animal's le ft .  A ligature  was placed around the in fe r io r 
vena cava, just above the renal vein, but was not tied. The hepatic 
porta l vein was cannulated using a 22 g x 32 mm cannula and the liv e r  
perfused (30 m l/m in) w ith  C a ^^-free  Krebs Ringer phosphate b u ffe r 
containing 5 mM glucose, equilibrated at 37o^ g^d gassed continuously
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(95% 0^15%  COg). The composition o f the C a^^-free  Krebs Ringer 
phosphate bu ffe r (pH 7.4, a t 20°C) was:
150 mM NaCl 4.84 mM NagHPO^
4.97 mM KC l 0.64 mM M gCl2.6 H2O
1.24 mM K H 2P d^ 0.62 mM MgSO^.7 H2O
3.73 mM NaHCO^
The in fe rio r vena cava was cut below the ligature  to prevent 
swelling o f the live r. The thoracic cav ity  was exposed by cu tting  
through the rib  cage and the in fe rio r cava cannulated above the live r via 
the rig h t a trium , using an 18 g x 32 mm cannula; the liga ture  previously 
placed on the in fe rio r vena cava was tied o ff.  A fte r  15 min the 
perfusion medium was replaced fo r a fu rthe r 15 min w ith  C a^^-free  
bicarbonate bu ffe r containing 5 mM glucose, equilibrated at 37°C and 
gassed continuously (95% 0 2 / 5% CO2). The composition o f the 
C a^^-free  bicarbonate bu ffe r (pH 7.4, a t 20°C) was:
142 mM NaCl 24 mM NaHCO^
4.37 mM K C l 0.62 mM MgSO^.7 H2O
1.24 mM KH 2P0 ^ 0.6 mM M gCl2-6 H2O
The live r was subsequently perfused w ith  150 m l C a^^-free  
bicarbonate bu ffe r, pH 7.4, containing 100 mg collagenase and 
1 mM CaC l2» w ith  re -c ircu la tio n  fo r up to 20 m in. The live r was rap id ly  
excised and suspended in Krebs-Hensele it bu ffe r, pH 7.4, containing 
5 mM glucose, 0.5 mM CaC l2 and 50 pM EOT A. The composition o f the 
Krebs-Hensele it bu ffe r (pH 7.4, at 20°C) was:
118 mM NaCl 1.12 mM MgSO^.7 H2O
4.83 mM K C l 24 mM NaHCO^
0.96 mM K H 2P0 ^ 20 mM HEPES pH 7.4, a t 20°C
The outer capsule o f the live r was removed, the tissue teased apart 
w ith  forceps and the cell-mass passed through bolting c lo th  (125 u).
Cells were washed three tim es by cen trifuga tion  (1 min a t 400 r.p .m .) 
and resuspended in fresh medium.
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Cell v ia b ility  was assessed by the trypan blue exclusion method
(100 gl trypan blue dye; 250 gl cell suspension) using a haemocytometer 
for cell counts. Cell y ie ld was routine ly over 200 x 10^ cells w ith  
v iab ilities  > 90%.
^'2.9 Quin II Loading and Fluorescence Measurements in In tact Hepatocytes
Quin II (Figure 3.5) is a te tracarboxy lic  acid which binds Ca^^ w ith  
1 : 1 sto ich iom etry and has an e ffe c tive  dissociation constant o f 115 nM 
in ionic media chosen to simulate mammalian cytosol (Tsien et al., 1982); 
Ca -binding is associated w ith  a f iv e -fo ld  increase in the fluorescence 
signal of the ind icator. Cells are loaded w ith  Quin II by incubation w ith  
its acetoxym ethylester, Quin II/A M , which readily permeates the plasma 
and is hydrolysed in the cytoplasm, thus trapping the impermeant 
quinoline species.
COX ^C O X  Quin 2 X = 0“
Quin 2/AM X = OCH.OCOCH_ 
COX %  I ^ j
L  / — COX CH]
2 +Figure 3.5 S tructure of Ca 
in d ica to r Quin 2 and i ts  
acetoxymethyl ester Quin 2/AM
Hepatocytes were resuspended at cell densities of approxim ate ly 
4 X 10^ ce lls /m l; 10 ml aliquots o f ce ll suspension were incubated w ith  
50 gM Quin II/A M  for 5 min at 37°C w ith  gentle shaking and constant 
gassing (95% Ü2/5% CO2). Stock solutions of Quin II/A M  were made up 
in dry d im ethyl sulphoxide (DMSG) and stored dessicated at -20°C  before 
use.
A fte r  loading, cells were centrifuged (1 min at 400 r.p.m .) to 
remove excess, undissolved Quin II/A M  and resuspended in C a ^^-fre e  
Krebs-Henseleit medium, pH 7.4, at a ce ll density o f 2 x 10^ Qells/m l.
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Fluorescence measurements were made w ith  a Perk in -E lm er LS-5 
luminescence spectrom eter ( Xex = 339 nm; Xem = 492 nm). 
Measurements were made w ith  3.0 m l s tirred  ce ll suspensions s tirred  in 
therm ostatted quartz cuvettes.
3.2.10 Analysis o f Data
S ta tis tica l analyses are presented under the appropriate Figure or 
Table. The s ta tis tica l significance o f differences found between groups 
was assessed using Student's t - te s t.
3.3 RESULTS
3.3.1 Characterisation o f the M itochondria l Fraction
Figure 3.6 shows the d istribu tion o f marker enzymes, DNA and 
prote in in the m itochondria l frac tion  obtained from  d iffe re n tia l 
cen trifuga tion  o f guinea-pig live r. There was no d iffe rence in 
d is tribu tion  o f the marker enzymes in the m itochondria l fractions 
isolated in the 0.25 M sucrose, 2 mM EGTA medium (Figure 3.6A) or in 
medium containing m itochondria l Ca^^ transport inhib itors (Ruthenium 
Red, m ersalyl) (Figure 3.6B). M itochondria l fractions were re la tive ly  
free o f contam inating endoplasmic re ticu lum  or plasma membranes as 
evidenced by the low recovery o f glucose-6-phosphatase and 
phosphodiesterase a c tiv ity . Contam ination by nuclei (DNA m arker) was 
negligible. Lysosomes are recovered over a broad density range which 
overlaps tha t at which m itochondria are sedimented (Reinhart e t 
^ . ,  1982a); m itochondria l fractions prepared by d iffe re n tia l 
cen trifuga tion  m ight reasonably be expected to contain s ign ifican t 
contam ination by these organelles. Consideration o f Figure 3.6 shows 
tha t lysosomes were the major contam inant : comparison o f to ta l and 
la ten t 3-glycerophosphatase a c tiv itie s  indicates tha t the m a jo rity  o f the
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Figure 3.6 DISTRIBUTION OF MARKER ENZYMES, DNA AND PROTEIN IN MITOCHONDRIAL 
FRACTION OBTAINED FROM DIFFERENTIAL CENTRIFUGATION OF GUINEA-PIG
LIVER HOMOGENATE
o
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30
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10
D POR LGP GP G6P D POE S LGP GP G6P P
Isolation Medium Key
250 mM sucrose 0 - ONA
2 mM EGTA, pH 7.6 POE - Phosphodiesterase
S - Succinate dehydrogenase
250 mM sucrose LGP - Latent g-glycerophosphatase
2 mM EGTA GP - Total 6-glycerophosphatase
10 mM MERS G6P - Glucose 6-phosphatase
5 pM Ruthenium Red, pH 7.6 P - Protein
Results are presented as means ± S.E.M. fo r  four independent experiments
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F igure  3.7 ELECTRON MICROGRAPHS OF MITOCHONDRIAL FRACTION ISOLATED IN : 
A  250 mM sucrose, 2 mM EGTA; pH 7 .6 .
B  250 mM sucrose, 2 mM EGTA, 10 pM MERS, 5 pM RR; pH 7 .6 .
M a g n ific a tio n  X 24,000; (M) M ito ch o n d ria , (L) Lysosomes
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contam ination was due to  in ta c t lysosomes. These findings were 
confirm ed by e lectron-m icroscopy (Figure 3.7).
3.3.2 E ffe c t o f Systematic A lte ra tio n  o f Isolation Conditions on the Tota l
Calcium Content o f L ive r M itochondria
M itochondria were prepared from  the livers o f contro l and trea ted
rats (phenform in HC l, 120 mg/kg, i.p.) and guinea-pigs (phenform in HC l,
30 mg/kg, i.p.) in isolation media containing combinations o f
m itochondria l Ca^^ transport inh ib itors and EGTA. In both the ra t
(Table 3.1) and the guinea-pig (Table 3.2), adm in istra tion o f phenform in
2+
in vivo appeared to have no s ign ifican t e ffe c t on m itochondria l Ca
fo llow ing isolation o f m itochondria in sucrose only. Although
m itochondria l Ca^^ appeared to be lower in the liv e r o f
phenform in-treated rats fo llow ing isolation o f m itochondria under most
of the other experim ental conditions, these differences did not achieve
significance at p < 0.05. In contrast, guinea-pig live r m itochondria l
Ca^"^ was s ign ifican tly  decreased fo llow ing the adm in istra tion o f
phenform in, under a ll isolation conditions except tha t o f sucrose alone.
Under optimum conditions fo r the mesurement o f m itochondria l
A
Ca i.e. in the presence o f EGTA, Ruthenium Red, mersalyl and 
succinate (discussed in 3.4), ra t live r m itochondria l Ca^"^ was m arg ina lly 
decreased (non-sign ificant) by 14.3% from  2.1 - 1.8 nmol Ca^’‘"/mg 
prote in; guinea-pig live r m itochondria l Ca^^ was decreased by 62.5% 
from  5.6 - 2.1 nmol Ca^^/m g prote in (p < 0.001).
3.3.3 Comparison o f the E ffec ts  o f Phenform in, 4-Hydroxyphenform in and 
M etfo rm in , in vivo, on Guinea-Pig L ive r M itochondria l Ca ~^^
In contrast to phenform in at 30 mg/kg (Table 3.2), a m olar 
equivalent dose o f 4-hydroxyphenform in (32 mg/kg), i.p .) had no
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Figure 3.8 GUINEA-PIG LIVER MITOCHONDRIAL FOLLOWING 4-HYDROXYPHENFORMIN
ADMINISTRATION IN VIVO
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Saline control
4-Hydroxyphenformi n
Male guinea-pigs (approximately 300 g) received 4-hydroxyphenformin HCl 
(32 mg/kg; i . p . )  ; control animals received equivalent volumes of sa line . 
Animals were k i l le d  a f te r  4 hours, l iv e rs  removed and mitochondria iso la ted 
in 0.25 M sucrose, pH 7.6, containing 2 mM EGTA, 5 mM succinate, 10 pM MERS 
and 5 pM RR. Values are means ± S.D. (n = 4 ) .
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Figure 3.9 GUINEA-PIG LIVER MITOCHONDRIAL Ca FOLLOWING METFORMIN
ADMINISTRATION IN VIVO
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Saline control
Metformin
Male guinea-pigs (approximately 300 g) received metformin HCl (500 mg/kg; 
i . p . ) ;  control animals received equivalent volumes o f sa line . Animals were 
k i l le d  a f te r  3 hours, l iv e rs  removed and mitochondria iso lated in 0.25 M sucrose, 
pH 7.6, containing 2 mM EGTA, 5 mM succinate, 10 pM MERS and 5 pM RR. Values 
are means ± S.D. (n = 4).
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Figure 3.10 GUINEA-PIG LIVER MITOCHONDRIAL FOLLOWING PHENFORMIN
ADMINISTRATION IN VIVO
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Male guinea-pigs (approximately 300 g) received phenformin HCl (30 mg/kg; i . p . ) ;
control animals received equivalent volumes o f sa line . Test and control animals
received pentobarbitone (60 mg/kg; i . p . )  4 hours a f te r  dosing with phenformin. 
Blood samples were drawn from the in fe r io r  vena cava. L iver mitochondria were 
iso lated in 0.25 M sucrose, pH 7.6, containing 2 mM EGTA, 5 mM succinate,
10 pM MERS and 5 pM RR. Values are means ± S.D. (n = 4).
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sign ificant e ffe c t on m itochondria l Ca "^*" a fte r 4 h in subsequently 
isolated guinea-pig live r m itochondria (Figure 3.8). Guinea-pigs given 
m etform in (500 mg/kg, i.p.) showed d is tinc t c lin ica l signs o f
hypoglycaemia a fte r 3 h; m itochondria l Ca^^, as measured in 
subsequently isolated m itochondria, was s ign ifican tly  decreased 
(p < 0.02) in trea ted guinea-pigs (2.1 + 0.78 nmol Ca^^/m g protein) 
compared to controls (4.00 + 0.83 nmol Ca^’^ /mg protein) (Figure 3.9).
In an a ttem pt to  compare the e ffec ts  o f phenform in on live r 
m itochondrial Ca^^ w ith  m etabolic e ffec ts  in v ivo , te rm ina l blood 
samples were taken from  contro l and trea ted guinea-pigs fo r the analysis 
of lacta te  and glucose. W ithdrawal o f samples from  animals k illed  by 
cervica l dislocation was not found to be en tire ly  satis factory because o f 
the tendency fo r blood to c lo t in situ; w ithdraw al o f blood samples under 
pentobarbitone anaesthesia, p rio r to removal o f the live r, proved more 
satis factory. Plasma glucose concentrations were s ign ifican tly  
decreased (p < 0.001) in animals receiving phenform in; blood lacta te  
concentrations were s ign ifican tly  increased (p < 0.001) over contro l 
values (Table 3.3). Both plasma glucose and blood lacta te  concentrations 
were s ligh tly  decreased (p < 0.05 and p < 0.02, respective ly) in 
phenform in-treated animals receiving pentobarbitone compared w ith  
those k illed  by cerv ica l dislocation; contro l values were unaffected. 
There was no d iffe rence in m itochondria l Ca^^ from  e ither contro l or 
phenform in-treated guinea-pigs when livers were removed under 
pentobarbitone anaesthesia (Figure 3.10) compared w ith  s im ila r 
experiments in which the animals were k illed  by cerv ica l dislocation.
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Figure 3.11 VARIATION IN GUINEA-PIG LIVER MITOCHONDRIAL Ca '^  ^ WITH TIME
AFTER DOSING WITH PHENFORMIN
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Saline control
2 h a f te r  phenformin
4 h a f te r  phenformin
Male guinea-pigs (approximately 300 g) received phenformin HCl (30 mg/kg; i . p . ) ;  
control animals received equivalent volumes of sa line . Test and control animals 
received pentobarbitone (60 mg/kg; i . p . )  at the times ind icated. Blood samples 
were withdrawn from the in fe r io r  vena cava. L iver mitochondria were iso la ted 
in 0.25 M sucrose, pH 7.6, containing 2 mM EGTA, 5 mM succinate, 10 pM MERS,
5 pM RR. Values are means ± S.D. (n = 4).
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Figure 3.12 PLASMA GLUCOSE AND BLOOD LACTATE IN GUINEA-PIGS, 2 - 4 HOURS
AFTER PHENFORMIN ADMINISTRATION IN VIVO
GLUCOSE LACTATE
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Experimental de ta i ls  were as in the Legend to Figure 3.11.
Values are means ± S.D. fo r  between 4 and 7 ind iv idua l observations.
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3.3.4 E ffe c t of Phenform in Adm in istra tion  in vivo on Guinea-Pig L iver 
M itochondria l during the Hyperglycaemic Phase o f Drug Action
Although not s ta tis tic a lly  s ign ificant, there was a tendency 
towards decreased live r m itochondria l Ca^^ a fte r 2 h in guinea-pigs 
treated w ith  phenform in (30 mg/kg, i.p.). Mean values were decreased 
from  5.2 + 1.38 nmol Ca^^/m g protein in controls to 3.9 + 0.32 nmol 
Ca^^/m g protein in treated animals (Figure 3.11). M itochondria l Ca^^ 
was fu rthe r decreased (1.52 + 0.51 nmol Ca^^/m g prote in) in treated 
animals k illed  a fte r 4 h.
In contrast to the hyperglycaemia (14.6 + 7.05 mM) in treated 
animals k illed  a fte r 2 h, plasma glucose concentrations fe ll to w e ll below 
contro l values (6.6 + 1.44 mM) and showed a marked hypoglycaemia (0.2 
+ 0.23 mM) a fte r 4 h (Figure 3.12). Blood lacta te  concentrations were 
s ign ifican tly  increased (p < 0.001) a fte r 2 h (5.7 + 1.71 mM) but were not 
s ign ifican tly  d iffe re n t from  blood levels in treated animals k illed  a fte r 
4 h (5.9 + 0.92 mM).
3.3.5 E ffe c t o f Phenform in in vivo on L ive r M itochondria l Ca ~^^  in the Starved 
Guinea-Pig
Starvation s ign ifican tly  decreased (p < 0.01) liv e r m itochondria l 
Ca^^ in contro l guinea-pigs from  mean values o f 4.7 + 0.64 nmol 
Ca^^/m g protein to 2.9 + 0.48 nmol Ca^^/m g prote in (Figure 3.13). 
Corresponding plasma glucose concentrations were s im ila rly  decreased 
(p < 0.05) from  8.0 + 1.16 mM in fed animals to 6.1 + 0.94 mM in starved 
guinea-pigs (Figure 3.14); blood lacta te  concentrations were unaltered.
Phenformin (30 mg/kg, i.p.) fu rthe r decreased (p < 0.01) 
m itochondria l Ca^^ in the livers of starved guinea-pigs; mean values (1.3 
+ 0.27 nmol Ca^^/m g protein) were lower than those in m itochondria 
isolated from  fed animals trea ted w ith  phenform in (2.0 + 0.86 nmol
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Figure 3.13 EFFECT OF PHENFORMIN ADMINISTRATION ON LIVER MITOCHONDRIAL
Ca '^  ^ IN STARVED GUINEA-PIGS
Saline control (fed)
Saline control (fasted)
Phenformin (fasted)
ex
4->
CD
CO
Male guinea-pigs (approximately 300 g) were randomised 
indicated, fasted animals were deprived o f food fo r  24 
water ad 1ib itum . Treated animals received phenformin 
controT"animals received equivalent volumes of sa line , 
received pentobarbitone (60 mg/kg; i . p . )  a f te r  4 hours, 
drawn from the in fe r io r  vena cava. L iver mitochondria 
sucrose, pH 7.6, containing 2 m.M EGTA, 5 mM succinate. 
Values are means ± S.D. (n = 3 - 4 ).
in 3 groups. Where 
hours but were allowed 
HCl (30 mg/kg; i . p . ) ;
Test and contro l animals 
Blood samples were 
were iso lated in 0.25 M 
10 pM MERS and 5 pM RR.
- 86 -
Figure 3.14 EFFECT OF PHENFORMIN ADMINISTRATION IN VIVO ON PLASMA GLUCOSE 
AND BLOOD LACTATE CONCENTRATIONS IN FASTED GUINEA-PIGS
GLUCOSE LACTATE
Saline control (fed)
Saline control (fasted)
Phenformin (fasted)
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Experimental de ta i ls  were as in the Legend to Figure 3.13.
Values are means ± S.D. fo r  between 2 and 4 ind iv idua l observations
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Ca^^/m g protein; combined data derived from  Figure 2.10, Figure 2.11) 
although the d ifference was not s ign ifican t at p < 0.05. Glucose 
Concentrations were lowered (p < 0.001) and lacta te  concentrations
increased (p < 0.02) compared to starved controls. A dm in istra tion o f 
phenform in resulted in lower plasma glucose concentrations in starved 
guinea-pigs (0.1 + 0.01 mM) than in fed animals (0.3 + 0.20 mM) 
(Table 3.3), although the ' d ifference was not s ta tis tica lly  s ign ifican t. 
Blood lacta te  concentrations were higher (p < 0.05) in starved 
guinea-pigs (8.6 + 2.16 mM) (Figure 3.14) than in fed animals treated 
w ith  phenform in (5.2 + 1.25 mM) (Table 3.3).
3.3.6 E ffe c t o f Phenform in in vivo on L ive r M itochondria l Ca^^ in Hamsters
A novel graduated-dose procedure was used to determ ine the 
maximum non-le thal, in traperitoneal dose o f phenform in in Golden 
Syrian hamsters (Table 3.4). Hamsters proved to be re la tive ly  resistant 
to the tox ic  e ffects  o f phenform in w ith  no evident signs o f to x ic ity  
below the range 120 - 180 mg/kg (i.p.) and an apparent maximum 
non-le tha l dose o f 200 mg/kg (i.p.).
Phenformin (200 mg/kg, i.p.) s ign ifican tly  increased (p < 0.05) liv e r 
m itochondrial Ca^^ from  2.9 + 0.29 nmol Ca^Vm g prote in in contro ls, to
4.3 + 0.9 nmol Ca^'^'/mg protein in treated animals a fte r 4 h
(Figure 3.15). Phenform in-treated animals were both hyperglycaem ic 
(13.6 + 5.16 mM; p < 0.01) and hyperlactataem ic (6.4 + 1.46 mM; 
p < 0.001) compared w ith  saline controls (6.8 + 1.42 mM and 2.0 + 
0.57 mM, respectively) (Figure 3.16).
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Table 3.4
Investigation o f Phenform in Tox ic ity  by In traperitoneal (i.p.) 
In jection, and Estim ation o f Maximum N on-Letha l Dose in the Hamster
Procedure based upon a proposal by the Acute T ox ic ity  Working Party 
o f the B ritish  Toxicology Society
TEST DOSAGE RESULT ACTION
30 mg/kg 
(n = 20
No evident to x ic ity * R e -tes t @ 60 mg/kg
60 mg /kg 
(n = 2)
No evident to x ic ity Re-test @ 120 mg/kg
120 mg/kg 
(n = 2)
No evident to x ic ity R e -tes t @ 180 mg/kg
180 mg/kg 
(n = 2)
One animal w ith  evident 
to x ic ity  3 hours post-dose
R e -tes t @ 200 mg/kg
200 mg/kg 
(n = 2)
Slight convulsions in 
im mediate post-dose period. 
Evident signs o f to x ic ity  at 
4 hours post-dose.
R e -tes t w ith  larger 
sample. Assay blood 
metabolites.
*  Evident to x ic ity : Signs o f to x ic ity  o f a su ffic ien t severity tha t trea tm ent at the 
next dose level is like ly  to lead to s ign ifican t m o rta lity .
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Figure 3.15 HAMSTER LIVER MITOCHONDRIAL FOLLOWING PHENFORMIN
ADMINISTRATION IN VIVO
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Male hamsters (approximately 100 g) received phenformin (200 mg/kg; i . p . ) ;  
contro l animals received equivalent volumes of sa line . Test and control 
animals received pentobarbitone (60 mg/kg; i . p . )  a f te r  4 hours. Blood 
samples were drawn from the in fe r io r  vena cava. L iver mitochondria were 
iso la ted  in 0.25 M sucrose, pH 7.6, containing 2 mM EGTA, 5 mM succinate, 
10 pM MERS and 5 pM RR. Values are means ± S.D. (n = 4)
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Figure 3.16 PLASMA GLUCOSE AND BLOOD LACTATE IN HAMSTERS, 4 HOURS
AFTER PHENFORMIN ADMINISTRATION IN VIVO
GLUCOSE LACTATE
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Saline control
Phenformin
Experimental de ta i ls  were as in the Legend to Figure 3.15.
Values are means ± S.D. fo r  between 8 and 12 ind iv idua l observations.
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Figure 3.17 EFFECT OF PHENFORMIN ON QUIN 2 FLUORESCENCE IN
ISOLATED INTACT RAT HEPATOCYTES
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3.3.7 E ffe c t o f Phenform in on In trace llu la r Homeostasis in In ta c t
Hepatocytes
The addition o f phenform in (5 mM) to a suspension o f isolated ra t 
hepatocytes loaded w ith  Quin 2 caused an increase in fluorescence 
associated w ith  an elevation in cytoplasm ic Ca^'*’ (Figure 3.17). 
Maximum elevated Ca^^ concentration was achieved by 2.5 min and 
maintained fo r a fu rthe r 2 min, a fte r which the cytoplasm ic Ca^^ 
concentration fe ll to below the in it ia l level. Q uantita tive  measurements 
o f Ca^^ concentrations were not determined.
3.4 DISCUSSION
D iffe re n tia l centrifugation  methods allow fo r the iso lation of 
coupled m itochondria in high yields but result in fractions contam inated 
to various degrees w ith  other organelles. Long preparation tim es may 
allow a s ign ifican t re -d is tribu tion  o f m etabolites or ions between 
organelles; techniques fo r the rapid frac tiona tion  o f cells have been 
developed but these are not applicable to the frac tiona tion  o f in ta c t 
tissue and result in crude m itochondria l fractions (Murphy et a l., 1980; 
Scott e t ^ . ,  1980). Reinhart e t W., (1982a) described a rapid method fo r 
the isolation o f in tac t m itochondria from  perfused ra t liv e r by the use o f 
discontinuous Percoll density gradients: using this technique i t  was 
demonstrated tha t Ca^^ movements leading to 5 -fo ld  changes in 
m itochondria l Ca^^ may occur during m itochondria l preparation and tha t 
the value fo r subsequently determined m itochondrial calcium  content is 
highly dependent upon both the concentration o f ex tra -m itochond ria l 
Ca^^ and the presence or absence of inh ib itors of m itochondria l Ca^^ 
transport (Reinhart et al., 1984a).
Fractions prepared by an adaptation o f the d iffe re n tia l 
cen trifuga tion  technique o f Chappel^and Hansford (1972) were shown to
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be m itochondria-enriched (Table 3.5) and to contain only lim ite d  
contam ination by other organelles excpet lysosomes (Figure 3.6, 
Figure 3.7). Rapid ce ll fractiona tion  techniques have shown tha t 
70 - 80% o f to ta l in trace llu la r Ca^^ is located in the m itochondria in 
hepatocytes (Murphy et a l., 1980); the endoplasmic re ticu lum  (or 
m icrosomal) frac tion  appears to account fo r most o f the 
non-m itochondria l Ca^^ although in in ta c t tissues, 10 - 20% o f to ta l 
Ca^^ is superfic ia lly  bound to the external surface o f the plasma 
membrane (Langer, 1978) but which is easily displaced w ith  EGTA 
(C la re t-B erthon et W., 1977). No evidence to suggest s ign ifican t 
accum ulation o f Ca^^ by lysosomes has been reported. Determ inations 
o f m itochondria l Ca^^ content (nmol Ca^^/m g protein) reported here 
may be s ligh tly  lower than true values (nmol Ca^^/mg m itochondria l 
protein) because of the fa ilu re  to take in to account contributions to 
prote in measurements by prote in o f non-m itochondria l orig in.
The e ffe c t o f system atica lly a ltering the isolation conditions on 
the to ta l calcium  content o f ra t and guinea-pig liv e r m itochondria 
(Table 3.1, Table 3.2) indicates tha t s ign ifican t Ca^^ movements occur 
during the isolation o f m itochondria. The addition o f Ruthenium Red to 
the sucrose isolation medium had no s ign ifican t e ffe c t on m itochondia l 
Ca^^ in ra t live r (Table 3.1); the addition o f EGTA decreased the Ca^^ 
content by 52%; a combination o f Ruthenium Red and EGTA reduced 
Ca^^ content to 26% of values obtained fo r the isolation o f m itochondria 
in sucrose only. These values confirm  tha t a combination o f EGTA and 
Ruthenium Red removed a ll external Ca^^ and inhib ited m itochondria l 
Ca^^ uptake (Reed and Bygrave, 1974b; 1975); Reinhart e t al., 1984a 
reported a 40% decrease in m itochondria l calcium content a fte r iso lation 
in 1.6 pM Ruthenium Red and 10 pM EGTA; s im ilar results were 
obtained using guinea-pig live r m itochondria (Table 3.2).
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Bernardi and Azzone (1982) have suggested th a t the membrane 
potentia l may regulate phosphate-stimulated Ca^^ e fflu x  from  
m itochondria; in addition, m ersalyl has been shown to in h ib it the para lle l 
e fflu x  o f Ca^"^ and phosphate in energised ra t live r m itochondria. 
Addition o f succinate and m ersalyl to isolation medium containing EGTA 
and Ruthenium Red increased the m itochondria calcium  content o f 
isolated contro l guinea-pig liv e r m itochondria by 40% (Table 3.2); 
addition o f succinate and m ersalyl to the isolation medium had no e ffe c t 
on ra t live r m itochondria l Ca^^ (Table 3.2), indicating tha t Ca^^ e fflu x  
from  ra t live r m itochondria may be very low under these conditions. The 
reported contro l value fo r ra t live r m itochondrial calcium  content (2.1 +
0.26 nmol Ca^^/m g prote in) is in close agreement w ith  the values 
reported by Reinhart et a l., (1984a) o f 2 - 3 nmol Ca^^/m g prote in fo r 
ra t live r m itochondria isolated under s im ilar conditions (10 mM 
succinate, 10 pM EGTA, 1.6 pM Ruthenium Red and 0.4 mM nupercaine) 
and claimed to be representative o f calcium content in v ivo . Values fo r 
guinea-pig live r m itochondria l Ca^^ under identica l iso lation conditions 
(Figure 3.18) were 5.6 + 0.16 nmol Ca^^/m g protein.
A dm in istra tion o f phenform in in vivo s ign ifican tly  decreased 
m itochondria l Ca^^ in subsequently isolated m itochondria (Table 3.2). 
The d ifference was s ign ifican t under a ll isolation conditions except w ith  
sucrose alone; the d ifference was most s ign ificant (62.5%) under the 
conditions designed to assess calcium  content in v ivo . Figure 3.19 
c learly  shows how altered Ca^’*’ homeostasis in vivo may be masked by 
Ca^^ red istribu tion in v it ro . In contrast to these results, D av ido ff and 
Haas (1979) demonstrated a s ign ifican t decrease in m itochondria l Ca^^ 
from  guinea-pig^ treated w ith  12 mg/kg and 30 mg/kg, i.p. Isolation o f 
m itochondria in the presence o f EOT A or Ruthenium Red caused a 
decrease in m itochondria l Ca^^; d ifferences between values from  con tro l
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PHENFORMIN ADMINISTRATION IN VIVO
Saline control
Phenformin
SUCROSE ONLY SUCROSE + ADDITIONS
Male guinea-pigs (approximately 300 g) received phenformin HCl (30 mg/kg; 
i . p . ) ;  control animals received equivalent volumes of sa line . Animals were 
k i l le d  a f te r  4 hours, l iv e rs  removed and mitochondria iso la ted in ( I )  0.25 M 
sucrose, pH 7.6 or ( I I )  0.25 M sucrose, pH 7.6, containing 2 mM EGTA,
5 mM succinate, 10 pM MERS and 5 pM RR. Values are means ± S.D. ( n = 4 ) .
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and treated animals were diminished and no longer s ign ifican t. D av ido ff 
and Haas ascribed the m itochondria l calcium  content o f m itochondria 
isolated w ith  Ruthenium Red as representing 'ionised in terna l Ca^"’’ plus 
a ll t ig h tly  complexed Ca^^ at inner and outer sites’. Since phenform in 
administered in vivo reduced the Ca^^ content almost as much as 
Ruthenium Red added during the isolation procedure, i t  was concluded 
tha t phenform in trea tm ent a ffected  the ’loosely complexed fra c tio n ’. 
Current th inking would ascribe the lowering o f m itochondrial Ca^^ by 
Ruthenium Red as being due to the inh ib ition  of Ca^'*' uptake during 
isolation, and ten ta tive ly  suggests tha t phenform in may have a s im ila r 
e ffe c t. Contro l values fo r the determ ination o f guinea-pig liv e r 
m itochondria l Ca^^ a fte r isolation in sucrose (14.6 + 2.96 nmol 
Ca^^/m g prote in; Table 3.2) are much lower than the values obtained by 
D avido ff and Haas a fte r isolation in sucrose-Hepes (27.8 + 0.3 nmol 
Ca^^/m g protein); a possible explanation fo r the lack o f a s ign ifican t 
e ffe c t by phenform in under these conditions (sucrose only; Table 3.2; 
Figure 3.19), in contrast to a highly s ign ifican t (p < 0.001) reduction due 
to phenform in (as reported by D avido ff and Haas), is tha t at higher 
m itochondria l Ca^^ loads any inh ib ito ry  e ffe c t of phenform in on Ca^^ 
uptake during m itochondria l isolation becomes more pronounced and 
hence results in greater differences in m itochondria l calcium  content 
between m itochondria from  contro l and treated animals. This find ing 
would suggest a persistent e ffe c t o f phenform in on isolated m itochondria 
fo llow ing in te raction  in v ivo . Addition o f phenform in to  guinea-pig liv e r 
m itochondria in v itro  has been shown to inh ib it Ca^^ uptake a t 
concentrations o f 1 mM and above (D avido ff, 1974) but enhanced the 
in it ia l ra te  o f uptake at concentrations below 50 pM (D avido ff e t 
al., 1978). Schafer (1980) has argued tha t the s tim u la to ry  e ffe c ts  o f low 
concentrations o f phenform in are incom patible w ith  the evidence th a t
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membrane potentia l dependent Ca^^ uptake can be m odified by the 
surface charge on the outside of the inner m itochondrial membrane. 
Although the amplitude o f calcium  uptake is uninfluenced by surface
potentia l, the ra te  constant o f the process is lowered. Schafer suggests 
tha t the apparent increase in Ca^"^ uptake in the presence o f low 
concentrations o f biguanides may be as a result o f inhib ited Ca^"^ e fflu x .
Follow ing adm in istration o f phenform in at concentrations which 
give rise to maximum elevated lacta te  concentrations in the ra t a fte r 
2g h (Guest et al., 1980), live r m itochondria l Ca^"'’ determ inations were 
lower than in controls, but differences were not s ign ifican t (Table 3.1). 
Guest (1978) demonstrated tha t blood lacta te  concentrations in the 
guinea-pig reached a maximum 4 - 5 h a fte r receiving phenform in 
(12.5 mg/kg, i.p.), at which tim e live r m itochondria l Ca^^ was 
s ign ifican tly  decreased (Figure 3.10). 4-Hydroxyphenform in (15.2 m g/kg,
i.p.) caused a slight increase in blood lacta te  concentrations in 
guinea-pigs a fte r 4 h, but had no hypoglycaemic e ffe c t (Guest, 1978);
4-hydroxyphenform in (32 mg/kg, i.p.) caused a small but non -s ign ifican t 
decrease in live r m itochondria l Ca^'*’ a fte r 4 h (Figure 3.8). Dubas and 
Johnson (1981) have shown tha t blood lacta te  reaches a maximum 
approxim ately 3 h fo llow ing in traperitoneal m etfo rm in  in fasted 
guinea-pigs; values fo r live r m itochondria l Ca^^ determ inations in fed 
guinea-pigs fo llow ing m etfo rm in  (500 mg/kg, i.p.) were s ig n ifica n tly  
lower than determ inations in contro l animals (Figure 3.9).
D ifferences between the e ffe c t o f hyperlactataem ic and 
hypoglycaemic doses o f phenform in on ra t and guinea-pig liv e r 
m itochondria l Ca^^, may suggest a d iffe re n t mechanism o f action o f the 
drug in the two species; guinea-pigs are more susceptible than ra ts to 
low doses o f phenform in. A lte rn a tive ly , Ca^"^ red is tribu tion  due to  
phenform in may not be susceptible to  detection by the ana ly tica l
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methods curren tly  employed, at the low levels o f Ca^^ found in ra t live r 
m itochondria. Further evidence fo r a causal relationship between 
depleted m itochondria l Ca^^ and the hyperlactataem ic and 
hypoglycaemic e ffe c ts  o f phenform in, is tha t the 4-hydroxy m etabolite 
has l i t t le  or no e ffe c t on blood lacta te  and glucose concentrations in vivo 
and has no s ign ifican t e ffe c t on live r m itochondrial Ca^^. The a b ility  o f 
the less lipoph ilic  biguanide, m etform in, to decrease m itochondria l Ca^^ 
a t a high dose level may suggest tha t a relationship exists between an 
e ffe c tive  biguanide concentration in vivo and altered m itochondria l 
function. The more lipoph ilic  the biguanide, the lower the dose required 
to produce an e ffe c t on m itochondria.
I t  was intended tha t determ inations o f blood lacta te  and plasma 
glucose concentrations be routine ly made in animals treated w ith  
phenform in, in order to establish any relationship between blood 
m etabolite  concentration in vivo w ith  m itochondria l Ca^^ in 
subsequently isolated live r m itochodria. In a thorough study o f the 
e ffec ts  o f various commonly used anaesthetic agents in sm all animals, 
Evans (1981) found tha t a number o f drugs had profound e ffe c ts  on 
glucose and lacta te  concentrations. I t  was found tha t although 
barb itu ra te  anaesthesia caused least perturbation o f blood m etabolite  
concentrations in contro l animals, pentobarbitone may in te rfe re  w ith  the 
m etabolic actions o f phenform in under certa in  conditions. 
Pentobarbitone caused a small, but s ign ifican t, decrease in blood 
m etabolite  concentration in guinea-pigs pretreated w ith  phenform in, 
compared to s im ila rly  treated animals k illed  by cerv ica l d islocation 
before w ithdrawal o f blood samples (Table 3.3); m etabo lite  
concentrations in untreated animals were unaffected. Barb itura tes block 
the oxidation o f NADH at the NADH dehydrogenase stage o f 
m itochondria l metabolism (Weiss et al., 1978): consequential increase in
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anaerobic glycolysis m ight explain the apparent poten tia tion  o f the 
hypoglycaemic e ffe c t o f phenformin by pentobarbitone-anaesthesia, 
although a s im ila r potentia tion o f hyperlactataem ia m ight also be 
expected. These e ffec ts  o f anaesthesia on blood m etabolite 
concentrations were considered insu ffic ien t as to invalidate 
demonstratable e ffec ts  o f phenform in on the same parameters; 
pentobarbitone had no e ffe c t on m itochondria l Ca^^ determ inations in 
the livers o f e ithe r contro l or phenform in pretreated guinea-pigs 
(Figure 3.10).
Adm in is tra tion  o f phenform in in vivo caused a tim e-dependent 
decrease in hepatic m itochondria l Ca^"^ in guinea-pigs (Figure 3.11). 
Guest (1978) demonstrated tha t adm in istra tion o f phenform in in 
anaesthetised guinea-pigs caused a massive hyperglycaemia, w ith  peak 
e ffe c t a fte r 2 h, followed by severe hypoglycaemia a fte r 3 - 4 h; 
D avido ff and Haas (1979) reported hyperglycaemic blood glucose 
concentrations, a fte r 3 h, in guinea-pigs receiving phenform in (30 mg/kg, 
i.p.). A s im ila r hyperglycaemic response to phenform in has been 
observed in rabbits (Kroneberg and Stoepel, 1958). Guinea-pig liv e r 
m itochondria l Ca^^ values were decreased by 26% a fte r 2 h (d is tinc t 
hyperglycaemia; Figure 3.12) and by 71% o f controls a fte r 4 h (severe 
hypoglycaemia; Figure 3.12); blood lacta te  concentrations were 
s ign ifican tly  increased over controls at both 2 and 4 h. Phenform in 
(200 mg/kg) caused an increase in blood glucose in hamsters a fte r 4 h 
(Figure 3.16); blood lacta te  concentrations were also increased. In 
unanaesthetised animals the drug caused no s ign ifican t change in liv e r 
m itochondria l Ca^^ although, as in the ra t, values were s ligh tly  lowered. 
In contrast, m itochondria l Ca^"^ in the livers o f anaesthetised, 
phenform in-treated hamsters were s ligh tly  greater than in contro ls, 
suggesting possible in terference w ith  the e ffec ts  o f phenform in by 
pentobarbitone anaesthesia (Figure 3.15).
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Figure 3.20 COMPARISON OF LIVER MITOCHONDRIAL IN THE GUINEA-PIG, RAT
AND HAMSTER FOLLOWING PHENFORMIN ADMINISTRATION IN VIVO
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Determ inations o f m itochondrial Ca^^ in the livers of 
unanaesthetised guinea-pig, hamster and ra t fo llow ing phenform in in 
vivo, are shown fo r comparison in Figure 3.20. These results would 
suggest tha t the guinea-pig is ce rta in ly  more sensitive to the e ffec ts  o f 
phenform in on in trace llu la r Ca^"^ homeostasis and may re fle c t 
d ifferences in the mode o f action of biguanides between the three 
species investigated. Moreover, experim ental evidence would suggest a 
closer corre la tion between hepatic m itochondria l Ca^"^ and blood 
lac ta te , ra ther than w ith  any e ffec ts  on glucose. A scatte r diagram 
(Figure 3.21) of combined data from  a number o f experim ental 
determ inations o f blood lacta te  and m itochondrial Ca^"^ in guinea-pigs, 
suggests a close corre la tion (r = 0.69; p < 0.001) between the two e ffec ts ; 
s im ila r trea tm ent of plasma glucose concentrations and m itochondria l 
Ca^^ (Figure 3.22) reveals no such relationship.
Inh ib ition of gluconeogenesis from  various precursors by biguanides 
is a w e ll established observation (Patrick, 1966; Meyer e t a l., 1967; 
A ltshuld and Kruger, 1968; Toews et al., 1970; Haeckel and 
Haeckel, 1972; Cook et a l., 1973; Ogata e t al., 1974; Lloyd et a l., 1975; 
Cook, 1978; Ho and K e lly , 1980; Evans et al., 1983). In fasted animals 
blood sugar is maintained almost exclusively by gluconeogenesis (Hanson 
and Mehlman, 1976); D avido ff and Haas (1979) found tha t fasted 
guinea-pigs were more sensitive to the hypoglycaemic e ffec ts  o f low 
doses of phenform in than were fed animals (a higher dose caused the 
hyperglycaemia discussed earlier); Connon (1973) has shown tha t isolated 
perfused livers removed from  fasted rats, are markedly more sensitive to 
phenform in inh ib ition  o f gluconeogenesis than are livers from  fed 
contro ls. Tw enty-four hour starvation caused a 37% reduction in liv e r 
m itochondria l Ca^^ in guinea-pigs (Figure 3.13); adm in istra tion  o f 
phenform in caused a fu rthe r decrease (57%), compared to untreated.
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starved controls. Corresponding blood lacta te  concentrations at 4 h 
(Figure 3.14) were greater than those determ ined in s im ila rly  trea ted  fed 
animals; plasma glucose concentrations were not s ign ifican tly  d iffe re n t
from  fed guinea-pigs a fte r phenform in. S im ilar e ffec ts  on blood glucose 
4 h a fte r phenform in in anaesthetised guinea-pigs were reported by 
Guest (1978); in the 24 h fasted guinea-pig blood lacta te  concentrations 
rose to less than 50% of s im ila rly  treated fed animals, suggesting 
possible in terference w ith  the m etabolic action o f phenform in by 
urethane anaesthesia (Evans, 1981). Decreased live r m itochondria l Ca^"^ 
in starvation would suggest a possible relationship between glucose 
metabolism and in trace llu la r Ca^"*" homeostasis. Although there is no 
clear evidence tha t changes in Ca^^ homeostasis are involved in the 
d irec t mechanism of glucagon action in the live r (W illiamson et 
al., 1981), D avido ff (1977) has suggested tha t the glucose lowering e ffe c t 
o f low concentrations o f phenform in may be due to lim ita tio n  o f 
glucagon-dependent gluconeogenesis through a mechanism involving 
in trace llu la r Ca^^ d istribu tion. Continuous m onitoring o f cytoplasm ic 
Ca^^, using a trapped in trace llu la r Ca^"^ ind ica tor in isolated 
hepatocytes, would suggest a transient increase in cytoplasm ic Ca^^ 
followed by a decrease to lower than in it ia l levels in response to  the 
addition o f phenform in to the incubation medium (Figure 3.17). Ca^"^ has 
an im portant role in the regulation o f live r metabolism (Williamson et 
cd., 1981); a lte ra tion  of Ca^^ concentrations in both the m itochondria l 
and cytoplasm ic compartments may produce s ign ifican t changes in the 
a c tiv itie s  o f a number of regulatory enzymes and in the response to 
hormones.
CHAPTER FOUR
EFFECT OF PHENFORMIN ADMINISTRATION IN  VIVO ON THE 
OXIDATION OF 2-OXOGLUTARATE AND SUCCINATE IN  
ISOLATED LIVER MITOCHONDRIA
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4.1 INTRODUCTION
The studies reported in Chapter 2 suggested tha t phenform in may 
exert an e ffe c t on in tra -m itochondria l enzymes by depletion o f 
m itochondria l Ca^^ jn  v it ro ; adm in istra tion o f phenform in to guinea-pigs 
in vivo caused a reduction in the to ta l calcium  content o f subsequently 
isolated live r m itochondria (Chapter 3). Denton et W., (1978) have 
proposed th a t Ca^^ may have an im portant role in the regulation o f 
oxidative metabolism in mammalian m itochondria by modulating the 
a c tiv itie s  o f three m itochondria l dehydrogenases: pyruvate
dehydrogenase, N A D ^-isoc itra te  dehydrogenase and 2-oxoglutarate 
dehydrogenase, a ll located exclusively w ith in  the m itochondria l inner 
membrane. Experiments using m itochondria l extracts have shown tha t 
the e ffec ts  o f Ca^^ on pyruvate dehydrogenase a c tiv ity  are brought 
about by changes in the proportion of the enzyme in its  active  non- 
phosphorylated fo rm : pyruvate dehydrogenase phosphate phosphatase is 
activated by Ca^^ (Denton et al., 1972,1975) while pyruvate 
dehydrogenase kinase may be inhib ited by Ca^^ (Cooper e t W., 1974). 
The overall e ffe c t o f Ca^^ is to increase the maximum a c tiv ity  o f 
pyruvate dehydrogenase, w ith  l i t t le  or no e ffe c t on the o f the 
enzyme w ith  respect to pyruvate.
In contrast, the e ffec ts  o f Ca^^ on N A D ^-isoc itra te  dehydrogenase 
and 2-oxoglutarate dehydrogenase appear to be more d irec t and lead to a 
greatly decreased fo r the ir substrates (th reo-D g-isoc itra te  and
oxoglutarate, respective ly) w ith  l i t t le  or no e ffe c t on the (Denton
et 1978; McCormack and Denton, 1979). The enzymes appear to have 
very s im ila r properties in extracts o f mammalian m itochondria from  a 
number o f tissues, including liv e r (McCormack and Denton, 1980) and in 
in tac t uncoupled m itochondria from  ra t adipose-tissue (McCormack and
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Denton, 1980). In addition, the activa tion  o f 2-oxoglutarate 
dehydrogenase by Ca^"^ has been demonstrated in coupled heart 
m itochondria (Denton et a l., 1980; Hansford and Castro, 1981; C oll et 
al., 1982).
Experiments were designed to investigate the a c tiv ity  o f 2- 
oxoglutarate dehydrogenase in live r m itochondria prepared from  guinea- 
pigs administered phenform in m v ivo . Test and contro l animals were 
k illed  3-4 hours a fte r dosing (dependent upon the response in treated 
animals), at which tim e blood lacta te  concentration is at a maximum 
(Guest, 1978). M itochondria were isolated under conditions which 
m aintain altered calcium  content established in vivo (Chapter 3). The 
a c tiv ity  o f succinate dehydrogenase, a m itochondria l enzyme located on 
the M -face o f the inner membrane but insensitive to Ca^^-m odulation 
(McCormack and Denton, 1980), was also investigated under these 
conditions.
Enzyme ac tiv itie s  were estim ated from  rates o f consumption,
using an oxygen-electrode, and on the assumption tha t the
dehydrogenases were ra te -lim itin g  fo r substrate oxidation (Denton e t al.,
1980; Bohnensack et ^ . ,  1982). Isolated m itochondria w ith  low to ta l
Ca^^ content w ill regulate m itochondria l free Ca^^ ra ther than ex tra -
m itochondria l Ca^^ when resuspended in medium containing no added
Ca^^ (N icholls, 1981; see 3.1). In the event o f any Ca^^ re -d is tribu tion
across the inner m itochondria l membrane, an e ffe c tive  d iffe re n tia l
in tra -m itochondria l free Ca^^ concentration should be maintained
between m itochondria isolated from  contro l and phenform in-treated
2+animals and hence m ight be expected to influence the a c tiv ity  o f Ca - 
sensitive in tra -m itochondria l enzymes.
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4.2 MATERIALS AND METHODS
4.2.1 Chemicals
N ,N ,N ',N ’-tetram ethyl-p-phenylenediam ine dihydrochloride (TMPD) 
and carbonyl cyanide 3-chlorophenylhydrazone (CCCP) were obtained 
from  Sigma (London) Chemical Co. L td ., Poole, Dorset, England.
Succinic acid, threo-D g(+)-isocitra te (monopotassium salt) were a ll 
supplied by Sigma and neutralised w ith  4M potassium hydroxide before 
use.
Other reagents were obtained from  the sources specified in 3.2.1. 
and 2.2.1.
4.2.2 Animals and adm in istra tion o f compounds
Sources o f animals were as outlined in 2.2.2; adm in istra tion o f 
compounds was as outlined in 3.2.2.
4.2.3. Isolation o f m itochondria
M itochondria were isolated essentially as described in 2.2.3. The 
isolation medium, 0.25M sucrose, pH 7.6, included 2mM EGTA, 5 mM 
succinate, 0.125 mM TMPD/1.25 mM ascorbic acid, 10 pM m ersalyl and 
5 pM Ruthenium Red where indicated.
A ll preparations o f m itochondria used in this study exhibited good 
respiratory contro l (Chance and W illiams, 1956). Acceptor contro l ra tios 
a t saturating concentrations o f substrate in m itochondria prepared from  
untreated animals were approxim ately 3 fo r the oxidation o f succinate, 
and 3-5 fo r the oxidation o f 2-oxoglutarate in the presence o f m alate 
(1 mM).
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4.2.4 Determ ination o f 2-oxoqlutarate and succinate dehydrogenase a c tiv itie s  
in isolated m itochondria
Incubations were carried out at 30°C in the reaction vessel o f a 
C lark-type oxygen-electrode as described in 2.2.6. Each incubation 
contained approxim ately 4 mg m itochondria l protein in a to ta l volume of 
2.0 m l bu ffe r. ADP and substrates were prepared in bu ffe r such tha t 10 
pi additions gave the indicated concentrations in 2.0 m l. M alate (Im M ) 
was present in determ inations o f 2-oxoglutarate dehydrogenase a c tiv ity , 
except where indicated. Malate potentia tes the transport o f 2- 
oxoglutarate in to m itochondria (DeHaan and Tager, 1968; Chappell, 
1968) and its e lf causes very l i t t le  consumption. Reactions were 
started by the addition o f substrate; State III (or uncoupled) respiration 
was determ ined as described in 2.2.6 (Figure 2.4) and is reported in a ll 
examples.
4.2.5 Measurement o f protein
Protein was determined by the method of Lowry et al., (1951).
4.2.6 Analysis o f data
Enzyme k ine tic  data is presented in the form  o f (v) versus [ S ] 
plots. Deviation from normal hyperbolic k inetics was investigated by 
f it t in g  data to equations o f the type
Determ ination o f the H ill co e ffic ie n t (n^ _^ ) was made from  plots o f 
(v)~^ versus log [S ]  (Kurganov, 1982). To determ ine the H il l  co­
e ffic ie n t, values o f v’,v and v" are in terpo lated from  the (v)” ^ versus
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log [S] p lo t at values o f log [ S ] l o g  [ S]  and log [5 ] ", respectively; 
lo g [S ] ' and log [S] " d iffe r  (plus and minus) from the m idpoint [S ]  by a 
constant m u ltip le , log K; nj_^  may be calculated from  the form ula
_ log I \ ^ / v ' - ^ /v  ) / ( ^ /v  - ^ /v "
log K
Calculated values fo r both 2-oxoglutarate and succinate oxidation were 
n ^  — 1 (normal hyperbolic function) under most conditions, except where 
indicated.
Derived values, and V , were determined from  Hanes-Woolf m max^
plots o f [S ] /v  versus [S ]  (Figure 4.1). A linear regression programme
r
was used to calculate lines o f best f i t  and hence determ ine K andm
V ; in terpo lated values o f (v) were used in c u rve -fitt in g  o f (v) verus max ^
[ S] plots. Where kinetics deviated from  hyperbolic, apparent values of
Hh
K and V were determined from  the plot o f f S 1 /v  versus m max ^
[S ]
4.3 RESULTS
4.3.1 E ffe c t o f phenform in (30 mq/kg; i.p.) in vivo on 2-oxoqlutarate oxidation 
in coupled guinea-pig liver m itochondria isolated in 0.23M sucrose, pH
7.6, containing 2 mM EGTA, 3 mM succinate, 10 pM m ersalyl and 5 pM 
Ruthenium Red
In the absence o f any exogenous substrate, m itochondria isolated 
under these conditions u tilised oxygen at an appreciable rate which 
remained constant fo r at least 30 minutes. Respiratory contro l was 
apparent upon addition o f ADP; s im ila r rates o f oxygen reduction were 
observed in both test and contro l m itochondria. The endogenous ra te  was 
progressively inhib ited by increasing concentrations o f disodium
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malonate; respiration was abolished, in the absence of added 2- 
oxoglutarate, a t a fin a l concentration 50 mM malonate in 2.0 ml 
incubation volume.
A t a ll concentrations o f 2-oxoglutarate investigated respiration 
was markedly lower in m itochondria prepared from  the live r o f the 
phenform in-treated animal than in the corresponding contro l (Figure 
4.2); m itochondria from  treated animals had a consistently lower to ta l 
calcium  content than controls when isolated under these conditions 
(Chapter 3).
K ine tic  data from  test and contro l m itochondria showed markedly
d iffe re n t characteris tics: contro l data gave a calculated H ill c o -e ffic ie n t
o f = 2.5; test data exhibited apparently normal hyperbolic kinetics
(K ^ ,  0.23 mM; 7.1 nmol O2 reduced/m in/m g protein). Apparent
values (K , 0.24 mM; V , 13.6 nmol reduced/m in/m g prote in) were m^ ’ max' 2 ^
2 5 2 5determined from  the p lo t o f [S] * /v  versus [ 5 ]  ’ fo r con tro l data.
Acceptor contro l ratios w ith  5 mM 2-oxoglutarate were lower than
expected (2.5 fo r contro l m itochondria; 1.9 fo r test m itochondria).
4.3.2 E ffe c t o f phenform in (30 m q/Kq; i.p.) in vivo on 2-oxoqlutarate oxidation 
in coupled guinea-pig live r m itochondria isolated in 0.25 M sucrose, pH
7.6, containing 2 mM EGTA, 0.125 mM TMPD/1.25 mM ascorbic acid, 
10 pM m ersalyl and 5 pM Ruthenium Red
Test and contro l m itochondria isolated under these conditions 
exhibited normal hyperbolic k inetics w ith  respect to 2-oxoglutarate 
(Figure 4.3). A t a ll concentrations investigated 2-oxoglutarate a c t iv ity  
was markedly lower in m itochondria prepared from  the treated animal; 
s im ila rly , m itochondria l Ca^^ in the treated animal (3.2 nmol Ca^^/m g 
protein) was markedly lower than in m itochondria from  contro l animals 
isolated under the same conditions (8.3 + 1.54 nmol Ca^^/m g prote in ;
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n = 2). V was considerably reduced from  19.4 nmolmax  ^ I
reduced/m in/m g prote in in the contro l animal to 2,4 nmol 
reduced/m in/mg prote in in m itochondria from  the phenform in-treated 
guinea-pig; corresponding values fo r were 0.15 mM in contro l and 
0.02 mM in test m itochondria. Acceptor contro l ratios w ith  saturating 
concentrations o f 2-oxoglutarate were 4.2 fo r contro l and 1.4 fo r test 
m itochondria.
4.3.3 E ffe c t o f phenform in (30 m q/Kq; i.p.) in vivo on 2-oxoqlutarate oxidation
in coupled guinea-pig live r m itochondria isolated in 0.25 M sucrose, pH
7.6, containing 2 mM EGTA, 10 pM mersalyl and 5 pM Ruthenium Red
Mitochondria isolated under these conditions exhibited hyperbolic
k inetics w ith  respect to 2-oxoglutarate (Figure 4.4); m itochondria l Ca^^
was s ign ifican tly  lower (p < 0.02) in the livers o f treated animals (4.9 +
1.40 nmol Ca^Vm g protein; n = 3) compared to controls (8.4 + 1.18 nmol
Ca^^/m g prote in; n = 4). 2-Oxoglutarate dehydrogenase a c tiv ity  in live r
m itochondria from  contro l guinea-pigs was compared w ith  the a c t iv ity  in
m itochondria isolated from  two animals which had received phenform in
(30 m g/Kg; i.p.) in vivo. Although the range of V values in contro l   ^ max
m itochondria was quite large (34.4 - 17.1 nmol reduced/m in/m g 
protein; mean value 23.2 + 6.87 nmol reduced/m in/m g prote in , n = 5), 
corresponding values in m itochondria from  treated animals (8.6 and 6.0 
nmol reduced/m in/m g protein) were considerably lower.
Corresponding values fo r were also decreased in test m itochondria 
(0.03 + 0.01 mM, n = 2) compared to controls (0.12 + 0.05 mM, n = 5). 
Acceptor contro l ratios were higher fo r m itochondria from  con tro l 
animals (3.2 - 4.9) than fo r m itochondria isolated from  trea ted guinea- 
pigs (2.1 and 2.2).
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4.3.4 E ffe c t o f phenform in (30 mq/kq; i.p.) in vivo on succinate oxidation in 
coupled guinea-pig live r m itochondria isolated in 0.23M sucrose, pH 7.6, 
containing 2 mM EGTA, 10 pM m ersalyl and 5 pM Ruthenium Red
Enzyme a c tiv ity  in both test and contro l m itochondria was
hyperbolic w ith  respect to succinate concentration over the range
investigated (Figure 4.5). A c t iv ity  was essentially s im ila r in both test
and contro l m itochondria, although was lower in m itochondria
from  the treated animal (34.1 nmol reduced/m in/mg protein
compared to 50.1 nmol Og reduced/m in/m g protein in the contro l).
Values fo r K were very s im ila r: 0.56 mM in contro l and 0.87 mM in test m ^
m itochondria. In contrast, the same m itochondrial preparations gave 
dissim ilar results when u tilis ing  2-oxoglutarate (10 mM): u tilisa tio n  in
m itochondria from  the treated guinea-pig (3.2 nmol Og reduced/m in/m g 
protein) was 11.6% o f contro l (27.9 nmol reduced/m in/m g protein).
Acceptor contro l ratios w ith  5 mM succinate were 3.0 and 3.6 fo r 
contro l and test m itochondria, respectively.
4.3.5 E ffe c t o f phenform in (30 mq/kq; i.p.) in vivo on 2-oxoqlutarate oxidation 
in coupled quinea-piq live r m itochondria isolated in 0.25 M sucrose, pH
7.6, containing 2 mM EGTA
Live r m itochondria from  phenform in-treated guinea-pigs had 
consistently lower levels o f to ta l Ca^^ when compared to controls 
isolated under these conditions (Chapter 3, Table 3.2). The ra te  o f O2 
consumption in both test and contro l m itochondria was hyperbolic w ith  
respect to 2-oxoglutarate concentration; substrate inh ib ition  was 
apparent at high concentrations o f 2-oxoglutarate (Figure 4.6). The 
pattern  o f inh ib ition in m itochondria isolated from  the phenform in- 
treated animal was s im ila r to tha t in Figure 4.4; was considerably
lower in test m itochondria (8.9 nmol Og reduced/m in/m g prote in)
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compared to contro l (36.9 nmol reduced/m in/m g protein). The value
fo r K in m itochondria from  the treated animal (0.03 mM) was low m
compared to the contro l value (0.17 mM). The acceptor contro l ra tio  
w ith  5 mM 2-oxoglutarate was 2.3 fo r test m itochondria and 3.6 fo r 
contro l.
4.3.6 E ffe c t o f Phenform in (30 m q/Kq; i.p.) in vivo on succinate oxidation in 
coupled quinea-piq live r m itochondria isolated in 0.23 M sucrose, pH 7.6, 
containing 2 mM EGTA
Both test and contro l m itochondria exhibited normal hyperbolic
kinetics over the range o f succinate concentrations investigated (Figure
4.7). Phenform in-treatm ent in vivo had no e ffe c t on succinate
dehydrogenase a c tiv ity  in subsequently isolated guinea-pig live r
m itochondria; values fo r (38.7 nmol O2 reduced/m in/m g prote in in
test m itochondria, 43.0 nmol O2 reduced/m in/mg protein in contro l
m itochondria) and K (0.39 mM in m itochondria from  the treatedm
animal, 0.50 mM in the contro l) were v ir tu a lly  identica l. D issim ilar 
results were obtained w ith  2-oxoglutarate (10 mM) as substrate: O2 
u tilisa tion  in m itochondria from  the treated guinea-pig (4.3 nmol O2 
reduced/m in/m g protein) was 19.8% o f contro l (21.7 nmol O2 
reduced/m in/m g protein).
Acceptor contro l ratios w ith  5 mM succinate were 3.0 and 3.4 fo r 
contro l and test m itochondria, respectively.
4.3.7 E ffe c t o f phenform in (30 m q/Kq; i.p.) in vivo on 2-oxoqlutarate oxidation 
in uncoupled quinea-piq live r m itochondria isolated in 0.25 M sucrose, pH
7.6, containing 2 mM EGTA
L ive r m itochondria from  contro l and phenform in-treated animals 
incubated in the presence o f the uncoupler CCCP (5 pM fina l
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concentration) exhibited hyperbolic kinetics w ith  respect to 2- 
oxoglutarate concentration (Figure 4.8). The pattern o f inh ib ition  in 
uncoupled m itochondria from  the phenform in-treated guinea-pig was 
s im ila r to the inh ib ition  o f coupled m itochondria incubated in the 
presence o f ADP (Figure 4.6): lowered (11.1 nmol O2
reduced/m in/m g prote in compared to 24.5 nmol reduced/m in/m g 
protein in the contro l) and decreased (0.04 mM compared to 0.12 mM 
in the contro l). In the absence o f uncoupler, acceptor contro l ra tios w ith  
5 mM 2-oxoglutarate were 4.5 and 1.6 fo r contro l and test m itochondria, 
respective ly.
4.4. DISCUSSION
Investigation o f the a c tiv ity  o f 2-oxogIutarate dehydrogenase in 
m itochondria isolated according to the conditions established in Chapter 
3 and thought to re fle c t m itochondria l calcium content established in 
v ivo, proved to be im practicab le. In the absence of fu rth e r exogenous 
substrate, m itochondria isolated in the presence of succinate u tilised  
oxygen at an appreciable rate which was enhanced by the addition o f 
ADP to the incubation medium. A bo lition  o f respiratory contro l and o f 
endogenous respiration by malonate, a specific inh ib ito r o f succinate 
dehydrogenase (Webb, 1966; Kappen et a l., 1973) indicated tha t 
m itochondria isolated under these conditions were massively loaded w ith  
succinate. State IV respiration was established by pre-incubation w ith  
50mM malonate and 0.2 mM ADP; subsequent addition o f 2-oxoglutarate 
in the presence o f ADP (State III respiration) caused a concentration 
dependent increase in the rate o f u tilisa tion . 2-O xoglutarate is 
transported in to m itochondria by a specific ca rrie r which fa c ilita te s  an 
e lectroneutra l exchange between 2-oxoglutarate, m alate, succinate.
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malonate and oxaloacetate; at high concentrations o f malonate (I^g = 
2mM; 30 pM 2-oxoglutarate) the transporter is com pe titive ly  inhib ited 
(Palm ieri e t al., 1972). Inh ib ition  of 2-oxoglutarate uptake may explain 
the deviation from  hyperbolic kinetics observed in contro l m itochondria 
at low concentrations o f substrate (Figure 4.2) as this e ffe c t was not 
seen in m itochondria obtained under other isolation conditions. The low 
rates o f u tilisa tion  at a ll concentrations o f 2-oxoglutarate may have 
precluded this e ffe c t from  becoming apparent in m itochondria isolated 
from  the live r o f a guinea-pig treated w ith  phenform in in v ivo .
Electrons may be supplied to the respiratory chain by the a r t if ic ia l
donor tetram ethyl-p-phenylenediam ine (TMPD) which is in turn reduced
by ascorbate. Electrons are accepted by cytochrome c, located on the
C-face o f the inner m itochondrial membrane: inclusion o f
TMPD/ascorbate in the isolation medium results in energised
m itochondria w ithou t the foregoing problem of succinate accum ulation.
Surprisingly, m itochondria isolated under the TMPD/ascorbate conditions
had a greater calcium content than m itochondria also isolated in the 
2+presence o f Ca -transport inhib itors but energised w ith  succinate 
(Table 3.2). A possible explanation fo r this d ifference may be tha t 
0.125mM TMPD/1.25 mM ascorbate and 5 mM succinate generate 
d iffe re n t membrane potentia ls and tha t this may modulate Ca^^ 
up take /e fflux  (Nicholls and Brand, 1980; Bernardi and Azzone, 1982) 
even in the presence o f Ruthenium Red and m ersalyl. Isolation o f
m itochondria w ith  EGTA, Ruthenium Red and m ersalyl, but in the
absence o f any energising substrate, resulted in s im ila r values o f 
m itochondria l Ca^^ to those obtained w ith  TMPD/ascorbate: these 
results suggest tha t 0.125 mM TMPD/1.25 mM ascorbate had a m in im al 
e ffe c t on the modulation o f Ca^^ transport. D ifferences in m itochondria l 
calcium  content were apparent between m itochondria isolated from
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phenform in-treated animais and controls, under both isolation conditions; 
rates o f 2-oxoglutarate oxidation were markedly lower in m itochondria 
w ith  reduced calcium  content in each case.
Adm in istra tion  o f phenform in in vivo had l i t t le  e ffe c t on succinate
oxidation in m itochondria isolated in the presence o f EGTA, Ruthenium
Red and mersalyl (Figure 4.5); in contrast, the rate o f 2-oxoglutarate
oxidation in m itochondria isolated from  the treated animal was 11.6% o f
the contro l value. In a d iffe re n t m itochondria l preparation isolated under
identica l conditions, adm in istration o f phenform in in  vivo resulted in
m ajor inh ib ition  o f 2-oxoglutarate oxidation across the concentration
range investigated (Figure 4.4). Moreover, 2-oxoglutarate oxidation in
m itochondria from  the treated animal showed l i t t le  varia tion  w ith
concentration o f substrate and most values were near V . Under thesemax
conditions i t  is d if f ic u lt  to determ ine a 'true ' value fo r K ^ ;  any apparent 
value w ill be very low. S im ilar results, i.e. inh ib ition o f 2-oxoglutarate 
oxidation in m itochondria from  phenform in-treated animals (Figure 4.6;
4.3.6) but no change in the rate o f succinate oxidation (Figure 4.7), were 
obtained in live r m itochondria isolated in the presence o f EGTA alone. 
Values fo r m itochondrial Ca^^ isolated under these conditions (Table 3.2) 
were s im ila r to the values obtained a fte r isolation o f m itochondria w ith  
Ruthenium Red and mersalyl, or w ith  Ruthenium Red, mersalyl and 
TMPD/ascorbate; differences in calcium content between m itochondria 
from  contro l and treated animals were s t il l apparent. I t  should be noted 
tha t in a number o f experiments guinea-pigs dosed w ith  phenform in 
fa iled to show any outward signs o f to x ic ity  (lethargy, trem ors e tc.); 
determ inations o f plasma glucose and blood lacta te  were w ith in  norm al 
ranges. The m itochondrial calcium content o f subsequently isolated liv e r 
m itochondria was sim ilar to contro l m itochondria; oxidation o f 2-
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oxoglutarate was uninhibited. This finding may suggest an all-or-none 
response to phenform in in v ivo ; a lte rna tive ly , the lack o f e ffe c t may be 
a ttribu tab le  to incorrect in tra -peritonea l dosing (e.g. in jection stra igh t 
in to the gut) although this could not be substantiated by gross 
observation at autopsy.
The absence o f any e ffe c t on succinate oxidation in m itochondria
from  phenform in-treated animals suggests no major im pairm ent o f
oxidative-phosphorylation by in terference w ith  proton re-uptake through
ATP synthetase , or w ith  P. and nucleotide transport. Im pairm ent o f 2-
oxoglutarate oxidation in both coupled (Figure 4.6) and uncoupled (Figure
4.8) m itochondria l preparations suggests no in terference w ith  proton
extrusion through Complex I o f the respiratory chain. Phenform in had no
e ffe c t on NADH-ubiquinone oxidoreductase in sub-m itochondrial
partic les (2.3.2). Furtherm ore, the s im ila r ity  o f the values fo r 2-
oxoglutarate oxidation under e ither coupled or uncoupled conditions fo r
both test and contro l m itochondria, suggests tha t the dehydrogenase
enzyme is the ra te -lim itin g  fac to r in m itochondrial substrate oxidation.
McCormack and Denton (1980) reported tha t the concentration o f ex tra -
m itochondrial Ca^'*' had no e ffe c t on the a c tiv ity  o f succinate
dehydrogenase in uncoupled m itochondria from  brown adipose tissue o f
cold-adapted rats; values fo r the (0.97 - 0.99 mM) were higher than
the values fo r the guinea-pig live r enzyme reported here (0.39 - 0.87
mM). In contrast, Ca^^ has been shown to increase the a c tiv ity  o f 2-
oxoglutarate dehydrogenase in uncoupled brown adipose tissue
m itochondria (McCormack and Denton, 1980) and in coupled ra t heart
m itochondria (Denton et a l., 1980; Hansford and Castro, 1981; C o ll et
W., 1982). In particu la r, Denton e t ^ . ,  (1980) showed tha t Ca^^ grea tly
diminished the K fo r oxoglutarate, w ith  no e ffe c t on V . Although m ^ max ^
the lack o f e ffe c t on succinate dehydrogenase a c tiv ity  in m itochondria
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containing reduced to ta l Ca^"^ is in complete agreement w ith  the results
of McCormack and Denton (1980), the pattern o f inh ib ition o f 2-
oxoglutarate dehydrogenase a c tiv ity  is not as expected. Although neither
McCormack and Denton (1980) nor Denton e t al., (1980) reported to ta l
m itochondrial Ca^"*" levels under the conditions o f the ir Ca^"^ t itra t io n
experiments, i t  has been shown tha t the activa tion  o f 2-oxoglutarate
dehydrogenase by in tra -m itochondria l free Ca^"^ in ra t heart
m itochondria is observed when the to ta l Ca^^ content rises w ith in  the
range 0.5 - 4 nm ol/m g m itochondria l protein (Hansford and Castro, 1981;
C o ll e t al., 1982). Re-suspension o f m itochondria isolated from  the livers
o f phenform in-treated guinea-pigs in medium containing no added Ca^^
should establish a lower steady state in tra -m itochondria l Ca^^
concentration than in corresponding contro l m itochondria. I t  is possible
tha t at the m itochondria l Ca^^ contents reported here (approximately
4-8 nmol Ca^^/m g protein) the activa tion  o f 2-oxoglutarate
dehydrogenase by Ca^^ has reached saturation. Increasing ex tra -
m itochondria l Ca^^ from  < InM  to 20 pM, decreased the K fo r 2-’ m
oxoglutarate from  2.32 mM to 0.54 mM (Denton e t ^ . ,  1980); values fo r
K reported here were a ll below 0.2 mM. m
Guinea-pig live r m itochondria, isolated under conditions considered 
to re fle c t m itochondrial Ca^^ in vivo (Chapter 3), contained 
approxim ately 2.5X the to ta l Ca^^ content o f ra t live r m itochondria 
isolated under the same conditions (Table 3.1, Table 3.2). I t  may be 
argued tha t maximal Ca^^ activa tion  w ill occur at higher values o f 
m itochondria l Ca^^ in isolated guinea-pig liv e r m itochondria i f  the 
regulation o f in tra -m itochondria l dehydrogenases is to have any 
significance in v ivo . On the strength o f this argument and on the basis o f 
the findings o f Denton e t ^ . ,  (1980), i t  may be predicted tha t a lower 
m itochondria l calcium content in live r m itochondria isolated from
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phenform in-treated animals w ill result in an increased fo r 2-
oxoglutarate, w ith  l i t t le  or no e ffe c t on The results reported here
(decreased K  , decreased V ) may suggest tha t the response of 2- m 111 a  X
oxoglutarate dehydrogenase to in tra -m itochondria l Ca^^ in guinea-pig 
live r is d iffe re n t to the activa tion  o f the enzyme in ra t heart or adipose 
tissue; a lte rna tive ly , phenform in may exert more than one e ffe c t (e.g. 
inh ib ition  o f the 2-oxoglutarate transporter) on m itochondria u tilis ing  2- 
oxoglutarate at concentrations o f m itochondrial free Ca^^ which may or 
may not be saturating. Further work is required to investigate the range 
o f m itochondria l calcium  content over which the sensitiv ity  o f guinea- 
pig 2-oxoglutarate dehydrogenase a c tiv ity  is altered. The m itochondria l 
2-oxoglutarate transporter must be considered as a possible locus fo r the 
mechanism o f action o f phenform in and would seem to w arrant 
investigation.
CHAPTER n V E
GENERAL DISCUSSION
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There is much evidence in this thesis tha t biguanides cause a 
reduction in m itochondria l Ca^^ both ]n v itro  (1.3.4) and m vivo (3.3.2 -
3.3.6). Evans e t al., (1983) have concluded tha t the basis of impaired 
ce llu la r respiration by phenform in is in the inh ib ition o f NADH 
dehydrogenase or o f m itochondria l NAD^-dependent dehydrogenases 
other than malate dehydrogenase. Pyruvate, isoc itra te  and 2- 
oxoglutarate dehydrogenases are sensitive to activa tion  by Ca^^ 
(McCormack and Denton, 1980); no such activa tion  has been reported fo r 
malate dehydrogenase. On theore tica l grounds, inh ib ition  o f 
m itochondria l NAD^-dependent dehydrogenases via depletion o f in tra - 
m itochondria l Ca^^ would result in inadequate energy production from  
oxidative phosphorylation and a consequent increase in anaerobic 
glycolysis. Overproduction o f lacta te  in peripheral tissue, and under­
u tilisa tion  o f lacta te  due to inh ib ition o f hepatic and renal 
gluconeogenesis, could account fo r both the hypoglycaemic and 
hyperlactataem ic action o f biguanides (A r ie ff  et 1980).
The regulation o f m itochondrial Ca^"*" transport may be m odified by 
a number o f in trace llu la r and extrace llu la r factors (reviewed by Fiskum 
and Lehninger, 1982). Lac tic  acidosis induced by phenform in is 
associated w ith  reduced in trace llu la r hepatic pH (Cohen, et ad., 1971; 
Lloyd, e t ^ . ,  1975; A r ie ff ,  et ^ . ,  1980); a decrease in pH (7.4 - 6.8) has 
been shown to induce the net release o f Ca^^ from  ra t live r 
m itochondria and has been in terpreted as due to stim u la tion  o f (Ca^^ - 
nH^) antiport-m ediated Ca^^ e fflu x  (Akerman, 1978); a decrease in pH 
o f the external medium has also been shown to in h ib it Ca^^ uptake in ra t 
kidney m itochondria (Studer and Borle, 1979). A lthough changes in 
in trace llu la r pH may m odify the e ffec ts  in v ivo , experiments w ith  
isolated m itochondria suggest tha t phenform in may a lte r m itochondria l
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2+Ca transport (D avidoff, 1974; D avido ff e t 1978) and m itochondria l 
calcium  content (Table 2.5); a lterations in in trace llu la r Ca^"^ 
red istribu tion  purely resu ltan t upon pH changes are unlike ly to persist in 
subsequently isolated m itochondria. Haeckel and Haeckel (1972) were 
the f irs t  to demonstrate th a t phenform in can markedly s h ift the 
m itochondria l oxidation-reduction state o f guinea-pig live r toward 
reduction; the oxidation-reduction state of in tra -m itochondria l pyridine 
nucleotides is a potentia l physiological regulator o f m itochondria l Ca^^ 
e fflu x  (Fiskum and Lehninger, 1982), however the net release o f Ca^^ 
from  respiring m itochondria isolated from  ra t live r, heart, or Ehrlich 
tumour cells, is associated w ith  a sh ift in the redox state o f 
m itochondria l pyridine nucleotides to a re la tive ly  oxidised condition 
(Lehninger et ^ . ,  1978; Fiskum and Lehninger, 1979). According to 
A ltshuld and Kruger (1968) phenform in causes a 40% reduction in ATP 
concentration in the isolated, perfused guinea-pig live r; since the role o f 
ce llu la r adenine nucleotides in the regulation o f m itochondria l Ca^^ 
transport is uncertain (Fiskum and Lehninger, 1982), any conclusion 
regarding decreased live r m itochondria l Ca^^ as a cause or e ffe c t o f 
respiratory inh ib ition  due to phenform in, must be treated w ith  caution.
There is some controversy in the lite ra tu re  as to whether the 
function o f the C a^^-transport system in the inner m itochondria l 
membrane should be considered p rim arily  as a means o f regulating in tra - 
m itochondria l ra ther than extra -m itochondria l free Ca^^ concentration 
(fo r reviews see N icholls and Crompton, 1980; Denton and M cCormack, 
1980); the physiological importance o f the activa tion  o f m itochondria l 
dehydrogenases by Ca^^ has also been questioned (Williamson and 
Cooper, 1980). Estimates o f m itochondria l Ca^^ in vivo bear d ire c tly  on
- 133 -
the c r it ic a l question o f whether the concentration o f m a trix  Ca^^ is 
appropriate fo r the regulation o f oxidative metabolism (discussed in 4.4); 
values fo r m itochondria l Ca^^ reported here would seem to be consistent 
w ith  the view (Denton et al., 1978; Denton and McCormack, 1980) tha t 
in tra -m itochondria l Ca^"^ concentration is a modulator o f flux  through 
pyruvate dehydrogenase and the trica rboxy lic  acid cycle under 
physiological conditions.
D avido ff (1977) has suggested tha t the glucose lowering e ffe c t o f 
low concentrations o f phenform in may be due to lim ita tio n  o f glucagon- 
dependent gluconeogenesis through a mechanism involving in trace llu la r 
Ca^^ d is tribu tion . Recent evidence suggests tha t in trace llu la r Ca^^ 
red is tribu tion  may be involved in the m ediation o f the liver's  response to 
glucagon (Baddams et al., 1983), although the recently held view was 
tha t Ca^^ was not involved in the d irec t action o f glucagon (Williamson 
et al., 1981). M obilisation of in tra -m itochondria l Ca^^ is ce rta in ly  
involved in the ce llu la r expression o f a-adrenergic agonist action in the 
live r (Williamson et al., 1981; Reinhart et al., 1982b; Taylor e t a l., 1983; 
Reinhart et ^ . ,  1984b). I t  is unlikely tha t insulin has a prim ary e ffe c t on 
in trace llu la r calcium  (Williamson et al., 1981); evidence against a role 
fo r Ca^^ in the activa tion  o f pyruvate dehydrogenase by insulin, has 
recently been published (Marshall et al., 1984). Glucagon has e ffe c ts  on a 
number o f regulatory enzymes: decreased flux  through glycolysis results 
from  inh ib ition  o f phosphofructokinase (Van Schaftingen, 1980) and 
pyruvate kinase (Thomas and Halestrap, 1981); increased m itochondria l 
pyruvate transport (Halestrap, 1978) and prom otion o f pyruvate 
carboxylase a c tiv ity  via increased m itochondria l ATP/ADP ra tios 
(Titheradge et al., 1979) have been proposed as po ten tia l sites o f 
glucagon-mediated stim ula tion o f gluconeogenesis (Thomas and
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Halestrap, 1981); s tim ula tion o f gluconeogenesis by increased fructose- 
1,6-diphosphatase a c tiv ity , involving a glucagon-induced decrease in the 
synthesis o f an e ffe c to r molecule, fructose-2,6-diphosphate, has also 
been proposed (Hue et al., 1981). The postulated consequences o f 
decreased m itochondria l Ca^^ i.e. inh ib ition o f m itochondria l 
respiration, consequent decrease in ce llu la r ATP/ADP ratios and hence 
enhanced a c tiv ity  o f phosphofructokinase (anaeorobic glycolysis) and 
reduced a c tiv ity  o f pyruvate carboxylase (inhib ition o f gluconeogenesis), 
are not inconsistent w ith  the view tha t phenform in may in te rfe re  w ith  
the expression o f glucagon action in v ivo . In addition, W illiamson e t ^ . ,  
(1981) have argued tha t in tram itochondria l Ca^'*' may regulate pyruvate 
carboxylase a c tiv ity , although activa tion  has been observed only at 
com paratively high values o f to ta l calcium  content (Foldes and B a rr it t ,  
1977); a decrease in m itochondria l Ca^^ would be predicted to  cause 
fu rthe r inh ib ition  o f gluconeogenesis from  pyruvate and lacta te .
An explanation o f how lowered m itochondria l Ca^^ during fasting 
is associated w ith  what must be presumed to be a predom inantly 
gluconeogenic state, is not easy i f  the arguments fo r an inh ib ition  o f 
gluconeogenesis by phenform in via in tra -m itochondria l Ca^^-depletion 
are to be accepted. Lowered m itochondria l Ca^^ a fte r fasting, reported 
here (3.3.5) and by D avido ff and Haas (1979) fo r m itochondria isolated in 
the presence o f EDTA, may re fle c t altered in trace llu la r Ca^^ 
d is tribu tion  resulting from  a culm ination o f hormonal actions which 
exert e ffec ts  on in term ediary metabolism other than via Ca^^; however, 
decreased m itochondria l Ca^^ during fasting may potentia te  the s im ila r 
e ffe c t o f biguanides on m itochondria and hence explain the increased 
sens itiv ity  o f starved animals to phenform in (D avidoff and Haas, 1979). 
In addition, a dim inution in response o f the pyruvate dehydrogenase
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system to activa tion  by both Ca^^ and pyruvate in starvation or diabetes 
has been demonstrated in ra t heart (McCormack e t al., 1982); under the 
conditions used by these workers, starvation and diabetes did not a lte r 
the response o f 2-oxoglutarate dehydrogenase in isolated m itochondria to 
changes in ex tra -m itochondria l Ca^^ concentration.
I t  is d if f ic u lt  to reconcile the e ffe c t o f a-adrenergic m obilisation 
o f in tra -m itochondria l Ca^^ and apparently accompanying increases in 
trica rb oxy lic  acid cycle a c tiv ity  (Taylor e t al., 1983) w ith  the Ca^^ 
regulation o f m itochondria l dehydrogenases, as proposed by Denton and 
McCormack (1980); however, a more recent report (Reinhart e t al., 
1984b) has suggested tha t the expression o f a-adrenergic-m ediated 
responses require the m obilisation o f both in trace llu la r and ex trace llu la r 
Ca^^ pools fo r the maintainance o f hormone-induced red is tribu tion  o f 
in trace llu la r Ca^^ which may involve an elevation in the cytoplasm ic 
concentration (Murphy et ^ . ,  1980; B a rr it t  et al., 1981). I t  remains to be 
seen whether elevation in cytoplasm ic Ca^^ is re flec ted  in the 
m itochondria and hence accounts fo r increased trica rb oxy lic  acid cycle 
a c tiv ity . I t  is in teresting to note tha t a-adrenergic agonists may 
stim ula te  gluconeogenesis from  reduced substrates such as g lycero l and 
sorb ito l by promoting the exchange of reducing equivalents from  the 
cytoplasm ic to the m itochondrial com partm ent (Kneer et ^ . ,  1979; Y ip 
and Lardy, 1981); a Ca^^-dependent activa tion  o f the m itochondria l 
glycerol-phosphate dehydrogenase was purported to play a m ajor role in 
this exchange mechanism (Yip and Lardy, 1981). G lycerol-phosphate 
dehydrogenase is localised in the C-face o f the inner m itochondria l 
membrane (Klingenberg, 1970) and hence is able to sense the 
concentration o f cytoplasm ic Ca^^ d irec tly ; gluconeogenic substrates 
such as g lycero l and sorb ito l may be o f po ten tia l use in the a llev ia tion  o f 
phenform in to x ic ity .
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In it ia l experiments w ith  the fluorescent ind ica tor, Quin 2, in
in ta c t ra t hepatocytes exposed to phenform in in v itro  (3.3.7) suggest tha t 
biguanides cause only a transient increase in cytoplasm ic Ca^^, a t least 
in the ra t. Work is curren tly  being undertaken in this laboratory to 
determ ine the e ffe c t o f phenform in on cytoplasm ic Ca^"^ in isolated 
guinea-pig hepatocytes. Elevation o f cytoplasm ic Ca^^ a fte r the 
adm in istra tion o f phenform in in vivo may explain the hyperglycaemia 
reported here fo r guinea-pig (3.3.4) and hamster (3.3.6), and by others fo r 
guinea-pig (Guest, 1978; D avido ff and Haas, 1979) and rabb it (Kroneberg 
and Stoepel, 1958). I t  is generally accepted tha t s tim ula tion o f hepatic 
glycogenolysis is m ainly due to m obilisation o f in trace llu la r Ca^^: an
associated increase in the concentration o f cytoplasm ic free Ca^^ 
results in the a llosteric  activa tion  o f phosphorylase b kinase which in 
turn phosphorylates and activates phosphorylase (Althaus-Salzmann et 
^ . ,  1980; Murphy et ^ . ,  1980; Coll et al., 1982; Reinhart et a l., 1982c; 
Charest et W., 1983). Reinhart e t W., (1984b) have demonstrated the
need fo r a m obilisation o f extrace llu la r Ca^^ in the maintainance o f a 
sustained glycogenolytic response in ra t live r. D ifferences in the 
mechanism of in trace llu la r Ca^^ homeostasis, in pa rticu la r the re la tive  
contributions o f the plasma membrane and the endoplasmic re ticu lum  to 
the regulation o f cytoplasm ic free Ca^"^, may explain the absence o f a 
hyperglycaemic response fo llow ing phenform in in the ra t (Guest e t a l., 
1980); ra t live r microsomes are known to have an active  MgATP- 
dependent Ca^"^ sequestration system which has a high a f f in ity  fo r Ca^^ 
(Moore et al., 1975; Bygrave, 1978); increased Ca^^ uptake by the 
endoplasmic re ticu lum , secondary to a rise in cytoplasm ic Ca^^ 
fo llow ing the addition o f norepinephrine to isolated ra t hepatocytes has 
been demonstrated by Murphy et al., (1980).
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A number o f compounds have been shown to a ffe c t the regulation 
o f m itochondria l Ca^^: prolonged feeding o f ethanol to rats resulted in 
increased Ca^^ e fflu x  in subsequently isolated liv e r m itochondria 
(Korsten e t 1983); Ca^^ uptake was enhanced in heart m itochondria 
isolated from  quin id ine-treated rats (Ocampo et 1984) and thought to 
explain the depressant e ffe c t on m yocardial contraction o f tox ic  doses o f 
quinidine by inducing low levels o f cytosolic Ca^^ and inh ib iting 
re laxa tion-contraction  coupling; the release o f m itochondria l Ca^^ by 
alloxan (Boquist, 1984; Frei e t 1985) and te rt-b u ty l hydroperoxide 
(Bellomo et 1984a) via oxidation and hydrolysis o f m itochondria l 
pyrid ine nucleotides is thought to contribute to the to x ic ity  o f these 
compounds; m obilisation o f in trace llu la r Ca^"^ by te rt-b u ty l 
hydroperoxide is associated w ith  increased cytosolic Ca^^ and activa tion  
o f phosphorylase (Bellomo et al., 1984b); the to x ic ity  o f the mushroom 
poison phalloidin, including inh ib ition o f oxidative-phosphorylation, 
disturbed m itochondria l function and decreased hepatic ATP 
concentration, may be associated w ith  the depletion o f the m itochondria l 
Ca^^ com partm ent o f isolated hepatocytes demonstrated by Faulstick et 
a l., (1984). O f pa rticu la r in terest is the e ffe c t o f endotoxin 
(lipopolysaccharide constituent o f the outer ce ll w a ll o f gram -negative 
bacteria) on m itochondria l substrate metabolism and in trace llu la r Ca^^ 
in cultured neuroblastoma cells (K ilpa trick-S m ith  and Erecinska, 1983): 
decreased in trace llu la r Ca^^ o f cells exposed to endotoxin was shown to 
be associated w ith  inh ib ition  o f tr ica rboxy lic  acid cycle a c tiv ity  because 
o f decreased flux  through pyruvate dehydrogenase as a result o f reduced 
amounts o f the enzyme in the active non-phosphorylated fo rm . R e la tive  
proportions o f active and inactive pyruvate dehydrogenase are governed 
by phosphorylatioryde-phosphorylation reactions which are sensitive to
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(4.1). K ilpa trick -S m ith  and Erecinska (1983) concluded tha t a block 
in pyruvate oxidation could explain previously reported decreases in 
NADH/NAD'*' and ATP/ADP ratios (K ilpa trick-S m ith  e^ al., 1981) and 
result in the stim u la tion  o f lacta te  fo rm ation  from  enhanced anaerobic 
glycolysis. Increased lacta te  form ation and ensuing la c tic  acidosis as a 
result o f exposure to endotoxins has been reported by a number of 
investigators in both experim ental and c lin ica l situations (Schumer and 
Erve, 1975; Hinshaw, 1976; M e rr ill and Rosolowsky, 1980; Sayeed, 1982).
Ca^^ is im portan t fo r the proper functioning o f nerve cells: 
increased in trace llu la r Ca^'*’ can cause an increase in spontaneous 
transm itte r release (Rubin, 1970); inh ib itors o f m itochondria l Ca^^ 
uptake have been shown to potentia te  tran sm itte r release (Alnaes and 
Raham inoff, 1975). Sweetman and Esmail (1982) have demonstrated a 
reduction in ra t brain m itochondria l Ca^^ fo llow ing the adm in istra tion o f 
A lthesin, halothane and hexobarbitone in vivo and have concluded tha t 
the concentration o f Ca^^ in the cytoplasm o f brain cells may be 
elevated during anaesthesia, thereby in te rfe ring  w ith  Ca^^-dependent 
a c tiv itie s  such as tran sm itte r release and membrane e x c ita b ility . These 
findings may explain the onset o f convulsions in mice administered high 
doses o f phenform in (2.3.1), an observation which is therefore  not 
incom patible w ith  an e ffe c t o f phenform in on in trace llu la r Ca^^ 
homeostasis; Biebuyck et ^ . ,  (1972) have reported tha t halothane also 
inh ib its  gluconeogenesis in ra t live r.
A postulated inh ib ition  o f NADH oxidation in vivo provides an 
explanation fo r the reported e ffe c t o f phenform in on the m itochondria l 
N A D H /N AD ’’’ ra tio : a s h ift towards a more reduced state (Haeckel and
Haeckel, 1972; Cook e t W., 1973; Ogata e t al., 1974; Cook, 1978) is not 
read ily  explained by an inh ib ition  o f Ca^^-sensitive m itochondria l 
dehydrogenases as any im pairm ent o f NAD^-linked reactions would be
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expected to result in the accum ulation o f oxidised pyridine nucleotides 
and a consequent decrease in the m itochondrial N A D H /N AD ^ ra tio . 
Evidence presented here suggests tha t the binding o f -phenformin to 
subm itochondrial partic les has no e ffe c t on the oxidation o f NADH by 
NADH-ubiquinone oxidoreductase (2.3.2). The inh ib ition  o f 2- 
oxoglutarate oxidation in coupled live r m itochondria isolated from  
phenform in-treated guinea-pigs (4.3.3; 4.3.5) is not consistent w ith  a 
s tra igh tfo rw ard  reduction in 2-oxoglutarate dehydrogenase a c tiv ity  as a 
result o f decreased in tram itochondria l Ca^^, although this mechanism 
may be involved (4.4). The persistance o f inh ib ition in uncoupled 
m itochondria l preparations (4.3.7) suggests tha t 2-oxoglutarate oxidation 
is not impaired as a result o f a ltered proton movements through Complex 
I o f the respiratory chain. Reduced proton flux  may explain the inh ib ition  
o f oxidative phosphorylation by re la tive ly  high concentrations o f 
phenform in (0.25 - 5 mM) in isolated m itochondria u tilis ing  both 2- 
oxoglutrate and succinate (2.3.3); succinate oxidation was unaltered in 
coupled m itochondria isolated from  phenform in-treated guinea-pigs 
(4.3.5; 4.3.7). I t  is unclear as to whether phenform in bound to 
m itochondria jn  vivo is retained in subsequently isolated m itochondria l 
preparations although any a lte ra tion  in membrane structure  and function  
may persist in v ivo . I t  is possible tha t phenform in may have a d ire c t 
action upon NADH-ubiquinone oxidoreductase (e.g. a ltered a f f in ity  o f 
NADH . dehydrogenase fo r substrate) which persists in isolated 
m itochondria but which is not apparent in subm itochondrial partic les due 
to some a lte ra tion  in membrane structure  as a resu lt o f th e ir  
preparation.
In conclusion, the results o f these investigations suggest tha t Ca^^ 
may have a role in the to x ic ity  o f phenform in. A reduction in 
m itochondria l calcium  content could account fo r the hyperlacta taem ic
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and hypoglycaemic e ffec ts  o f phenform in in v ivo ; the postulated 
mechanism suggests tha t elevated blood lacta te  concentrations are a 
consequence o f the hypoglycaemic e ffe c t. A specific locus fo r the action 
o f phenform in as a result o f decreased m itochondrial Ca^^ by the drug 
has not been elucidated; the mechanism by which phenform in exerts a 
clear inh ib ito ry  e ffe c t on 2-oxoglutarate oxidation is unknown, and may 
or may not involve modulation o f 2-oxoglutarate dehydrogenase a c tiv ity  
by a lte ra tion  in the concentration o f in tram itochondria l Ca^^. Further 
investigations should include examination o f the sens itiv ity  o f 2- 
oxoglutarate oxidation to changes in extram itochondria l Ca^^ 
concentration, and o f the e ffe c t o f added Ca^^-ionophore, in 
m itochondria isolated from  phenform in-treated animals. An under­
standing o f the e ffe c t o f m itochondria l Ca^^ depletion on pyruvate 
dehydrogenase a c tiv ity  in phenform in-treated animals is o f c r it ic a l 
in terest as this enzyme is po ten tia lly  more im portant in the regulation o f 
in term ediary metabolism.
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